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Abstract 
Photoswitchable ligands are used to control and study complex biological systems such as folding 
of proteins and peptides, enzymatic reactions or neuronal signaling. They are typically developed by conju-
gating photochromic compounds to known ligands so that exposure to light results in the change of the 
binding affinity of the ligand. Many light-responsive ligands are based on azobenzene, a molecule that un-
dergoes a pronounced change in geometry upon photoisomerization from trans to cis in picoseconds. Cur-
rently, photoswitchable ligands are available only to a limited number of targets and their development by 
rational design is complex. Furthermore, they show low affinity and a relatively small change in binding 
affinity between the cis and trans conformation. In my PhD work, I aimed at overcoming these shortcom-
ings by establishing an in vitro evolution method to generate light-controlled peptide ligands to targets of 
choice. Combining the expertise on phage display technology of the Heinis’ lab and the knowledge about 
azobenzene photoswitches of the Wegner’s lab, I screened large combinatorial libraries of cyclic peptides 
containing an azobenzene-based linker for the generation of light controlled ligands. 
In a first project I synthesized and studied the photochemical properties of oligo-ortho-
azobenzenes in order to get familiar with organic synthesis and azobenzene characterization. Even though 
several procedures are reported for the synthesis of azobenzene compounds, none of them was suitable for 
the preparation of ortho-nitrogen-substituted azobenzenes. Using a method that was previously developed 
in the Wegner group and that is based on modified Mills reaction conditions, I prepared several mono-, bis-, 
tris- and tetra- ortho-nitrogen-substituted azobenzenes. For the synthesis of bis-ortho-azobenzenes, a one-
pot procedure was used. The analysis of their UV-VIS spectra revealed that their absorbance depends on 
the substituents and that only the ortho-nitrogen substituted mono-azobenzenes underwent trans → cis 
isomerization upon UV irradiation. 
In a second project I aimed at developing a phage selection method for the isolation of pho-
toswitchable peptide ligands. The goal was to cyclize random peptides displayed on phage with a pho-
toswitchable azobenzene compound and to isolate in affinity selections those peptides that bind to an im-
mobilized protein target in either cis or trans conformation. As a model protein target, I used streptavidin. 
Phage-encoded peptide libraries with the formats CX7C and XCX5CX were cyclized with the linker 3,3'-
bis(sulfonato)-4,4'-bis(bromoacetamido)azobenzene, irradiated in situ with UV light and screened for the 
binding to streptavidin. Peptides isolated in two rounds of selection shared high sequence similarities. A 
range of peptides were synthesized and tested for binding streptavidin before and after irradiation at 365 
nm. Several peptides bound with high affinity when cyclized with the azobenzene linker and their affinity 
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could be modulated by UV light. The best peptide showed a 3-fold higher affinity in the cis compared to the 
trans conformation. 
In a third project, I applied the established phage selection method to a second target, the serine 
protease urokinase-type plasminogen activator (uPA) which is implicated in tumor growth and metastasis 
formation. A primary goal of this study was to develop photoswitchable peptide ligands that show a larger 
difference in binding affinity between cis and trans conformation. I had previously observed that the change 
in affinity depends much on the binding site of the peptide. I was therefore interested to find azobenzene 
peptides binding to many different epitopes of the uPA target. Towards this end, I applied high-throughput 
sequencing technology to analyze phage-selected peptides. This approach led to the identification of more 
than ten different consensus sequences. Peptides from six of these consensus sequences could be synthe-
sized and characterized. Peptides with the consensus motif VCXIIPYCR and WQERYCR showed the largest, 
yet relatively modest change in affinity. The result of this study confirmed that peptide ligands containing 
azobenzene groups can be developed to virtually any target with the new phage display-based approach. At 
the same time, the result showed that it is challenging to generate peptide ligands with large differences in 
affinity between the cis and trans conformation. The work suggests that new photoswitchable groups that 
impose larger conformational changes upon light switching should be developed and applied for the phage 
selection of light-responsive peptide ligands.  
Keywords 
photoswitchable peptides, cyclic peptides, phage display, azobenzene, streptavidin, photocontrol, uroki-
nase-type plasminogen activator. 
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Sommario 
Ligandi fotocontrollabili vengono utilizzati per monitorare e studiare sistemi biologici 
complessi come il folding (ripiegamento) di proteine e peptidi, le reazioni enzimatiche e il signaling 
(sistema di segnalazione) neuronale. Di solito i ligandi sono creati mediante la coniugazione chimica 
di composti fotocromatici con ligandi peptidici noti in modo tale che l’esposizione alla luce risulti in 
un cambiamento dell’affinità di legame del ligando stesso. Molti ligandi foto sensibili sono basati 
sull’azobenzene, una molecola chimica che, quando sottoposta a foto-isomerizzazione, subisce  in 
pochi millisecondi un notevole cambiamento della propria geometria strutturale da trans a cis. At-
tualmente sono disponibili peptidi ciclici foto controllabili solo per un numero ristretto di target  e il 
loro sviluppo razionale è assai complesso. Inoltre questi peptidi presentano una bassa affinità di 
legame, la quale risulta essere relativamente poco diversa tra la conformazioni cis e trans. Lo scopo 
del mio progetto di dottorato è stato superare queste limitazioni sviluppando un sistema di in vitro 
finalizzato alla scoperta di ligandi foto-controllabili per ben definiti target. Combinando le competen-
ze del laboratorio del Prof. Heinis in merito alla tecnologia del phage display e le conoscenze del 
laboratorio del Prof. Wagner a proposito della fotoisomerizzazione degli azobenzeni, ho potuto 
esaminare ampie librerie fagiche di peptidi ciclicizzati con un composto di natura azobenzenica in 
grado di generale ligandi foto controllabili. 
Nel primo progetto ho sintetizzato e studiato le proprietà fotochimiche di azobenzeni orto-
sostituiti per diventare familiare con la loro sintesi organica e caratterizzazione chimica. Sebbene 
siano note in letteratura diverse procedure per la sintesi degli azobenzeni, nessuna fra queste risul-
tava adatta per la sintesi di azobenzeni mono-bis-tris-tetra-orto-sostituiti con gruppi azotati. Appli-
cando una procedura precedentemente sviluppata nel laboratorio del Prof. Wagner e basata sulla 
modifica delle condizioni della reazione di Mills, ho preparato diversi azobenzeni mono-bis-tris-tetra-
orto-sostituiti con gruppi azotati. Per la loro sintesi si è applicata una singola reazione. L'analisi dei 
rispettivi spettri UV-Vis ha rivelato come la loro assorbanza dipenda dai sostituenti introdotti e che 
solo gli azobenzeni mono-orto sostituiti isomerizzano quando sottoposti a irradiazione con raggi UV.  
Lo scopo del secondo progetto è stato sviluppare un metodo di phage display per la sele-
zione di ligandi peptidici foto-controllabili. L'idea consisteva nel ciclizzare librerie peptidiche espresse 
dai fagi utilizzando un azobenzene foto-controllabile e nell’isolare i peptidi che legano la proteina 
target nella conformazione cis o trans. Come proteina modello si è scelta la streptavidina. Librerie 
fagiche che codificano per i format peptidici CX7C e XCX5CX sono state ciclizzate con il composto 
 vi 
 
BSBBA, irradiate in situ con luce UV e diversamente selezionate a seconda dell'affinità di legame per 
la streptavidina. Sequenze consenso ben definite sono state individuate dopo solo due round di 
selezione. Diversi peptidi selezionati sono stati sintetizzati e testati per definire la loro affinità di 
legame prima e dopo irradiazione a 365 nm. L'isomero cis ha rivelato una affinità di legame 3 volte 
superiore a quella dell'isomero trans.   
Nel terzo ed ultimo progetto ho applicato questo metodo di phage display precedente-
mente sviluppato ad un secondo target, la serin proteasi urochinasi (attivatore del plasminogeno), 
proteina implicata nei processi di crescita tumorale e metastasi. Il principale obiettivo di questo stu-
dio era sviluppare ligandi fotocontrollabili che mostrassero una maggiore variazione di affinità tra le 
conformazioni cis e trans. Come osservato in precedenza, il cambio di affinità dipende molto dal sito 
di legame del peptide. Di conseguenza era mio interesse cercare peptidi modificati con l'azobenzene 
in grado di legare epitopi differenti dell'urochinasi. Con questo scopo ho usufruito la tecnologia del 
sequenziamento di DNA ad alta prestazione per analizzare i peptidi precedentemente selezionati. 
Questo approccio ha permesso di indentificare piu' di 10 sequenze consenso diverse. È stato possi-
bile sintetizzare e caratterizzare solo peptidi appartenenti a 6 di queste famiglie di sequenze consen-
so. Peptidi con il consenso VCXIIPYCR and WQERYCR hanno mostrato la maggiore variazione di affi-
nità, sebbene sia comunque relativamente modesta, e hanno rivelato una migliore attivita inibitoria 
nella conformazione trans. Il risultato complessivo di questo secondo studio suggerisce come ligandi 
contenenti azobenzene possano essere identificati con il nuovo approccio da noi sviluppato. Allo 
stesso tempo lo studio dimostra che nuove molecole foto controllabili, in grado di introdurre più 
ampie variazioni conformazionali quando irradiate, debbano essere create e utilizzate per la sele-
zione di ligandi peptidici foto-controllabili.   
Parole chiave 
Peptidi fotocontrollabili, peptidi ciclici, sistema di display su fagi, azobenzene, streptavidina, fotocon-
trollo, urochinasi (attivatore del plasminogeno). 
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 Introduction Chapter 1
1.1 Objectives of the thesis 
The possibility to manipulate biomolecules in a spatio-temporal manner is of great interest 
because it potentially allows to study and control biological processes such as protein-protein inter-
action, enzyme catalysis and DNA replication. Thanks to their light-inducible isomerization proper-
ties, azobenzene-based compounds have been inserted into peptide ligands to control their struc-
ture and therefore generate photoswitchable ligands. However, the light-controlled binders report-
ed in literature are generated mainly by rational design and are therefore available only for a re-
stricted number of targets. Furthermore, they often have a low binding affinity and show a rather 
small change in affinity between the cis and trans conformation.  
The goal of my thesis was to overcome these limitations by developing an in vitro evolution 
strategy which allows the selection of photoswitchable peptide ligands from large combinatorial 
phage-encoded libraries. Towards this aim I have i) gained experience with azobenzene chemistry by 
synthesizing and studying several ortho-substituted azobenzenes, ii) established the procedures for 
the chemical modification of phage-displayed peptide libraries with a photoresponsive linker, iii)  
performed phage display selections against two model targets streptavidin and urokinase-type plas-
minogen activator (uPA), and iv) isolated light-responsive peptide ligands. 
1.2 Photomodulation of biomolecules using azobenzene  
1.2.1 Azobenzene, a brief overview 
Azobenzene is a diazine in which the hydrogens of the double bond NH=NH are substituted 
by phenyl rings. Its photoisomerization between cis and trans was first described by Hartley in 1936.
1
 
The trans isomer, characterized by a planar structure, isomerizes to the cis conformation upon UV 
irradiation. Its backisomerization can be mediated by thermal relaxation or by exposure to visible 
light. The azobenzene absorption spectrum is characterized by two bands: the first one is at around 
320 nm and corresponds to the π−π* transition (tran-cis isomerization) while the second one at 
around 430 nm corresponds to the n−π* transition (cis to trans backisomerization) (Figure 1.1).
2,3
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Figure 1.1. Absorption spectrum of an azobenzene compound. Figure taken from Merino et al. 2012.4  
Two main pathways of E → Z isomerization have been reported: rotation and inversion. In the rota-
tion mechanism, the double bond N=N is broken so that the single N-N bond allows the rotation. The 
inversion mechanism takes place in plane since the C-N=N-C angle is conserved while the N=N-C 
forms an angle of 180°C (Figure 1.2).
5
  
 
 
Figure 1.2. Schematic depiction of the mechanism of azobenzene backisomerization (rotation and inversion). Figure taken 
from Crecca et al. 2006. Permission approved by American Chemical Society (Copyright 2006).5  
Azocompounds were initially mainly used as dyes and pigments. However, due to their isomerization 
properties, they have also been applied for the photocontrol of cage-like structures, surfaces and 
polymers.
6,7
 Recently, the use of azobenzene compouds to regulate structure and function of bio-
molecules has raised particular interest as it would allow the control of biological processes in a 
spatial and temporal manner.
3
  
1.2.2 Photocontrol of nucleic acids, lipids and carbohydrates 
Several examples of nucleic acids manipulation using azobenzene derivatives have been re-
ported in literature. For example, Nakatani and co-workers proposed a method to induce DNA hy-
bridization of two single strands that would not happen spontaneously. They used an azobenzene 
molecule linked to two naphthyridine carbamate units that recognize guanidines. The formation of 
the dsDNA (double-stranded DNA) was allowed only after isomerization to the cis conformation and 
the process could be followed measuring the Tm (melting temperature) (Figure 1.3a).
8
 Komiyama and 
colleagues were able to modulate the activity of RNase H, an enzyme that is capable of degrading 
Chapter 1. Introduction 
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the RNA only when it is bound to its complementary DNA sequence (antisense DNA). They designed 
a DNA molecule complementary to the antisense DNA (sense DNA) that included one or multiple 
azobenzene units. When kept in the darkness, the sense DNA could hybridize with the antisense 
DNA, keeping it from binding to the RNA (and thereby preventing its degradation). When the azo-
benzene unit was irradiated, the DNA denaturated and the antisense DNA could hybridize with the 
RNA, allowing its degradation (Figure 1.3b).
9
 The effect of azobenzene isomerization on DNA con-
formation was further investigated by the Burghardt’s group. They generated an azobenzene teth-
ered DNA and showed that both isomers induced perturbation of the helical structure. Nevertheless, 
the trans isomer generated a more stable system thanks to stacking interactions of the azo unit with 
the base pairs.
10
    
 
 
Figure 1.3. a) Azobenzene modified naphthyridine carbamate units interact with guanidines and induce DNA hybridization 
upon UV irradiation. Figure taken from Dohno et al. 2007. Permission approved by American Chemical Society (Copyright 
2007).8 b) Azobenzene tethered DNA is denaturated after trans/cis isomerization and is recognized by the enzyme RNase H. 
Figure taken from Matsugana et al. 2004. Permission approved by American Chemical Society (Copyright 2004).9 
Photoresponsive phospholipids can be used to alter the structure of cell membranes and to 
control their biological properties. For instance, membrane permeability is extensively studied for its 
importance in drug delivery. Engberts and co-workers studied the effect of isomerization on lipid 
monolayers composed by both azobenzene modified and unmodified phospholipids 1,2-dipalmitoyl-
sn-glycero-3-phosphocholine (DPPC). They showed that the trans to cis isomerization favored inter-
action with water and therefore induced a higher degree of disorder.
11
 The same group synthesized 
and studied single and double-tailed azobenzene-substituted phosphate amphiphiles. Their isomeri-
zation to the cis form caused an alteration of the packing and this effect was stronger the closer the 
azobenzene unit was located to the head group.
12,13
 A method to control membrane morphology by 
light was also recently proposed based on a synthetic azo-amphiphiline. The changes of the vesicles 
properties where monitored by phase-contrast microscopy. They found that the photoswitch was 
inducing budding phenomena which could be explained with changes in membrane surface area.
14
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The interaction between proteins and carbohydrates is involved in many processes such as 
target recognitions and it is known to be the result of a complex net of interactions. Jayaraman tried 
to modulate the binding of carbohydrates to proteins linking an azobenzene core to several sugar 
units and studying their binding to lectin. They showed that carbohydrates units bound to the pro-
tein in a cooperative manner. The affinity was higher when the azobenzene core was switched to cis 
and the backisomerization rate was significantly slow.
15,16
 
1.2.3 Photoswitchable protein ligands 
Protein function is often regulated by the binding of a ligand that can act as inhibitor, activa-
tor or allosteric modulator. This process can be controlled in a spatial and temporal fashion by con-
jugating the ligand to an azobenzene unit or, alternatively, by introducing the azobenzene moiety 
into the protein of interest.
3
  
One of the first examples was reported by Erlanger et al.
17
 In this study, the known chy-
mostrypsin inactivator phenylcarbamylchloride was modified with an azobenzene unit to obtain p-
azophenyldiphenylcarbamylchloride (PADPCC). They showed that the enzyme inactivation was high-
er after isomerization of the trans isomer to the cis and that it was totally reversible after complete 
backisomerization.
17
 Few years later the same group described two light-controlled activators of the 
acetylcholine receptor, a protein which regulates the flux of ions in electrogenic membranes. They 
first synthesized 3,3′-bis[α-(trimethylammonium)methyl]azobenzene dibromide (Bis-Q). The trans 
form depolarized the membrane with a Kd of around 10
-7
 M while the cis counterpart had almost no 
activity. A similar result was obtained with 3-(α-bromomethyl)-3′-[α-
(trimethylammonium)methyl]azobenzene bromide (QBr) which was covalently attached to the re-
ceptor by reacting it with the reduced thiol groups of the protein.
18
 
Trauner and colleagues were able to regulate the inotropic glutamate receptor (iGluR) with 
photoswitchable moieties. This protein forms channel pores in neuronal cells and it is activated by 
the binding of glutamate. After structural studies, the agonist was linked to the channel through an 
azobenzene unit. Upon irradiation at 380 nm and isomerization of the photoswitchable core the 
ligand bound the receptor causing the opening of the channel and the flow of positive ions (Na
+
, K
+
, 
Ca
2+
) (Figure 1.4).
19
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Figure 1.4. Photocontrol of glutamate receptor by a covalently tethered azobenzene agonist. Figure adapted from Volgraf et 
al. 2006. Permission approved by Nature Publishing Group (Copyright 2006).19   
More recently, the same research group showed how the iGluR can be regulated using red-
shifted azobenzene molecules simplifying the use of the photoswitch in biological systems (more 
information about red-shifted azobenzene linkers in paragraph 1.2.5).
20
  
Gramicidin is a peptide which is known to form channels for monovalent cations in membranes. 
Woolley and co-workers covalently attached azobenzene moieties at each end of the peptide ion 
channel without altering its structure. After irradiation at 337 nm a change in current was observed 
although the channel was not fully blocked.
21
 Azobenzene could also be used to photocontrol antibi-
otic activity. Recently, the group of Feringa synthesized several photoswitchable antibiotics introduc-
ing an azobenzene core in quinolones. The compound that showed the largest difference between 
the trans and cis isomer had a MIC of respectively 16 µg/mL and 2 µg/mL and the inhibition of bacte-
rial growth could be reverted when incubated in the dark (Figure 1.5).
22,23
 
Figure 1.5. The quinolone-based compound (left) showed to inhibit bacterial growth only after irradiation at 365 nm. Figure 
adapted from Velema et al 2013. Permission approved by Nature Publishing Group (Copyright 2013). 22 
1.2.4 Photoswitchable aminoacids 
In 2005 Schultz reported the incorporation of azobenzene based amino acids into Escherich-
ia coli for the photoregulation of the catabolite activator protein (CAP). This protein is a transcription 
activator that controls several operons in bacteria. The unnatural amino acid was successfully intro-
duced into the protein using an amber codon. The change in affinity of CAP for a promoter contain-
ing a CAP binding site was measured and it was shown that after UV irradiation, the azobenzene 
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modified protein had a 4-fold lower Kb.
24
 In order to achieve photo-control of enzymes, Woolley 
tested the effect caused by the introduction of the unnatural aminoacid phenylazophenylalanine 
(PAP) in RNase S. This enzyme can be cleaved in two parts (called peptide S and protein S) by subtil-
isin causing the loss of its activity. It is known that the activity can be restored establishing a non-
covalent interaction between peptide S and protein S. Woolley synthesized several analogs of pep-
tide S introducing PAP at different positions, incubated them with protein S and measured the effect 
of PAP isomerization on enzyme activity. A maximum of 5-fold difference in the kinetic constant was 
reached upon irradiation.
25,26
 Mutants of the horseradish peroxidase were generated inserting L-p-
phenylazophenylalanine (azoAla) at different positions using an Escherichia coli in vitro translation 
system. The study revealed that the activity could be either increased or decreased depending on 
the azobenzene position and isomerization state. In the case of the mutant Phe179azoAla the en-
zyme was completely inactive in the cis form and the activity was recovered after backisomeriza-
tion.
27
 The group of Freitag modified the FLAG tag peptide DYKDDDDK by substituting two or three 
Asp residues with a photoswitchable amino acid. Two of the tested peptides showed a clear change 
in affinity for the anti-FLAG-tag antibody M1 of 130 and 300 times respectively after irradiation.
28
  
1.2.5 Photocontrol of peptides 
As peptides play a key role in countless biological processes, many attempts have been 
made in order to control their conformation and binding affinity in a light-controlled fashion.  In the 
last years great effort has been put into the establishment of light regulated systems by the intro-
duction of azobenzene moieties and many examples are reported in literature. 
1.2.5.1 Azobenzene-based molecules for the photocontrol of peptides 
Many studies have been made to optimize the properties of azobenzene-based linkers used 
for the photo-regulation of peptides. Several parameters should indeed be considered for the design 
of new linkers. As the trans isomer usually cannot be isomerized to 100% cis, it is preferable to pro-
duce peptides which affect the target activity only after UV irradiation. The yield of isomerization 
should be as high as possible to maximize the effect induced by the photoswitch while the half-life 
reduced or increased depending on the application. For in vivo use, higher excitation wavelengths 
(600-1200 nm) should be considered. It is indeed known that UV-light induces DNA mutations and 
that at wavelengths lower than 600 nm the tissue penetration is prevented by absorption of endog-
enous chromophores (i.e. hemoglobin). On the other hand, water absorbs at higher wavelengths 
(λ˃1200 nm).
23
  
(4-amino)phenylazobenzoic acid (APB, Figure 1.6, compound I1) and (4-
aminomethyl)phenylazobenzoic acid (AMPB, Figure 1.6 compound I2) are the linkers that were first 
used for peptide cyclization.
29
 They can be directly incorporated into the peptide backbone. AMPB 
presents an additional CH2 spacer to increase both flexibility and length. Upon isomerization the end 
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to end distance decreases from 12 to 9 Å. The red shift is also reduced due to the disruption of the π-
system by the CH2 group.
29,30
 3,4- or 3,3-AMPB were also used to induce the desired β-turn geometry 
of the peptide attached after UV irradiation.
31
  
Woolley and co-workers designed several linkers for amino acids side chain modification to 
introduce the photoswitch into peptides and proteins.
32-34
 They synthesized symmetric molecules to 
obtain only one product after peptide modification and reduced at the minimum the number of 
single bonds between the azo-core and the amino acids to maximize the conformational change 
upon UV irradiation.
35
 The first studies were performed using a diiodoacetamide azobenzene (I4) 
which allows the cross reaction with two cysteine side chains. The S-S distances were reported to be 
between 6 and 14.6 Å for the cis, 17.1-18.7 Å for the trans isomer and a 75% content of cis at the pss 
(photostationary state).
36
 In order to improve the solubility in aqueous solutions, the water soluble 
linker 3,3'-bis(sulfonato)-4,4'-bis(chloroacetamido)azobenzene BSBCA (I5) was synthesized.
32
 It 
showed an end-to-end distance of 11-15 Å for the cis and 19-23 Å for the trans. 
To induce a larger conformational change, longer and more rigid linkers were synthesized. 
Moroder and colleagues used compound I6 which showed an end-to-end distance of 12 Å for the 
trans and 7 Å for the cis to modulate collagen unfolding. Another example is represented by 3,3'-
diazene-1,2-diylbis{6-[2-sulfonato-4-(chloroacetylamino)phenylethynyl]benzene sulfonic acid 
(DDPBA, Figure 1.6, compound I7). Its length varies from 30-33 Å (trans) to 13-24 Å (cis) but unfortu-
nately it showed a low switching efficiency (24% at 20°C).
33
 To overcome this limitation Samanta and 
colleagues synthesized 4,4'-bis(4-(2-chloroacetamido)phenyl)diazenylbiphenyl (BPDB, Figure 1.6, 
compound I8a) and 4,4'-bis(4-(2-chloroacetamido)phenyl)diazenylbiphenyl-2,2'-disulfonate (BPDBS, 
Figure 1.6, compound I8b), two bis-azobenzene scaffolds. The S-S distance can go from 5 to up to 23 
Å and the cis isomer can be obtained in 80% yield upon UV-irradiation.
34
 
It is known that the introduction of substituents which stabilize the excited state of azoben-
zene leads to a red shift of the absorption spectrum (i.e. push pull systems). Sadovski et al. published 
recently several ortho-amino substituted cross-linkers which exhibited high ʎmax. It was observed 
that the higher is the red shift, the shorter is the half-life. Compound I9 showed the most prominent 
red shift (ʎmax 530 nm) even though its half-life was of only 0.7 sec.
37
 The group of Andrew Woolley 
reported that the introduction of bulky electron-rich substituents in ortho-position allows the isom-
erization in high yield ( ̴ 98%) with irradiation at 630-660 nm (compound I10a,b). The switching effi-
ciency was confirmed in vivo after injection in zebrafish embrios and the chlorinated linker showed 
resistance to glutathione-mediated reduction. Furthermore, unlike other red shifted azobenzene 
these molecules exhibited a slow backisomerization rate at 37°C, which ranged from 2 to 45 h de-
pending on the scaffold used.
38
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Figure 1.6. Structure of the most used azobenzene-based scaffold for photocontrol of cyclic peptides. 
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1.2.5.2 Peptides controlled with azobenzene-based molecules 
β-hairpin is a well-known secondary protein structure often involved in protein and peptide 
interactions. Renner and co-workers studied the folding of a β-hairpin peptide based on tryptophan 
zipper motif (Figure 1.7). They substituted the amino acids naturally forming the β-turn with [3-(3-
aminomethyl)-phenylazo)]phenylacetic acid (AMPP) (compound I3, Figure 1.6). After isomerization 
to cis the azobenzene core was supposed to mimic the β-turn motif. 
 
Figure 1.7. β-hairpin decapeptide containing the photoswitchable unit AMPP. Figure redrawn from Dong et al. 2006. 39 
They demonstrated that after trans to cis isomerization the tested decapeptide folds into the desired 
β-hairpin structure.
39
 Another example of β-hairpin photoswitchable peptide was developed by Bey-
ermann at al. based on the β-finger structure present in the PDZ domain of nNOS (nitric oxide syn-
thase). This motif is fundamental for the interaction of nNOS with α-1-syntrophin. The binding leads 
to the production of NO that plays a key role in muscle contraction. They generated a cyclic peptide 
that simulates the nNOS β-finger and incorporated an azobenzene based amino acid. Surface plas-
mon resonance (SPR) studies showed that the cis isomer was able to bind syntrophin with a Kd of 
10.6 µM, while the corresponding trans form was almost not binding at all the target protein (Table 
1.1 entry 1).
40
 In a following study the same group verified the effect of this cyclic peptide in living 
skeletal muscle fibers showing that the cis isomer inhibits almost completely the fiber contraction.
41
 
A similar approach was applied to generate photoswitchable somatostatin analogues. Somatostatin 
is a cyclic peptide involved in several biological processes such as neurotransmission, cell prolifera-
tion and regulation of the insulin/glucagon equilibrium. Its activity is determined essentially by four 
amino acids (Phe-Trp-Lys-Thr) which fold in a β-turn conformation. Ulysse et al. synthesized a cyclic 
octapeptide containing the sequence Phe-Trp-Lys-Thr and the β-turn conformation was induced by 
UV irradiation of the incorporated azobenzene unit. The cis isomer was found to inhibit the somato-
statin receptor with a Ki twice as much potent as the corresponding dark adapted form (Table 1.1, 
entry 2).
42
  
Azobenzene was also used to modulate other secondary structures such as α-helix. Moroder 
and collaborators developed a photoresponsive structure based on an octapeptide found in the 
active site of thioredoxin reductase that presents a 310-helix conformation. This short peptide was 
cyclized with 4-(aminomethyl)phenylazobenzoic acid (AMPB) (compound I2, Figure 1.6) to form a 
monocyclic peptide. An even more rigid bicyclic structure could be generated by oxidation of the two 
cysteine residues present in the sequence. NMR studies revealed that the trans isomer in the mono-
cyclic format induced a pretzel-like structure, more rigid than the corresponding relaxed cis form. 
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The trans-bicyclic peptide also showed a more structured conformation than the cis isomer which 
seemed not to show any structural preference.
29
 Woolley is one of the main expert in α-helix pho-
tomodulation.
35
 He synthesized different linkers such as diiodoacetamide azobenzene I4 (Figure 1.6) 
or 3,3'-bis(sulfonato)-4,4'-bis(chloroacetamido)azobenzene (BSBCA) I5 (Figure 1.6) which can react 
with two cysteine residues introduced at different spacing in the peptide sequence. He showed that, 
due to the different end to end distance, the helix formation is favored with i,i+4 and i,i+7 spacing 
when the linker I4 is in the cis conformation and i,i+11 if the scaffold is in the trans (Figure 1.8) 
3,32,33
 
 
 
Figure 1.8. Molecular models of peptide cyclized with compound I4 having a) i, i + 4 and b) i, i + 11 spacings between cysteine 
residues. Figure taken from Flint et al. 2002. Permission approved by Elsevier (Copyright 2002).43 
Recently, the same group published a study in which the photoswitching of a 4,4'-
bis(chloroacetamido)azobenzene modified peptide was controlled and monitored in vivo. Zebrafish 
embrios were injected with the compound coupled to fluorescein in order to monitor the isomeriza-
tion in real time. The proximity of the photoswitchable unit to the fluorophore was supposed to 
induce a change in the emission upon irradiation. In their system the fluorescence signal decreased 
during the isomerization to the cis form and it increased during the backisomerization proving that 
the photoswitching took place. In vivo, the percentage of cis/trans at the photostationary state was 
confirmed to be the same than in vitro while the half-life was 25% lower.
44
  
Bcl-XL is an antiapoptotic protein which was shown to have a role in cancer progression to-
gether with other members of the Bcl-2 family such as Bak and Bid. Structural studies revealed that 
Bak binds to Bcl-XL through an amphipatic helix. Alleman et al. designed several peptides based on 
Bak fragment responsible for Bcl-XL recognition.
45
 The peptides were synthesized with different 
cysteine spacing and cyclized with BSBCA I5 (Figure 1.6) to modulate the helix content and therefore 
the affinity for Bcl-XL upon isomerization of the linker. The binding of the different formats and iso-
mers to the target protein Bcl-XL could be controlled by UV irradiation and were measured  by fluo-
rescence polarization.
45
 The Kd values are reported in table 1.1, entry 3.  Several groups generated 
photoswitchable RGD (Arg-Gly-Asp) peptides to control cell adhesion that is important in biological 
processes such as immunological response, tissue healing and metastasis. Moroder and collabora-
tors for example synthesized a heptapeptide cyclized with AMPB containing the well-known integrin 
binding motif RGD. The binding affinity of the two isomers for αVβ3 integrin was measured by SPR 
(surface plasmon resonance). They were able to demonstrate that the cis form had a 40% lower 
Chapter 1. Introduction 
23 
 
binding affinity than the dark adapted isomer (Table 1.1, entry 4).
46
 Another example was reported 
by Kessler and coworkers. Several cyclo RGD peptides containing the 4-[(4-
aminophenyl)azo]benzocarbonyl linker were synthesized. It was shown that the trans form induced 
higher cell adhesion than the corresponding UV irradiated isomer (Table 1.1, entry 5).
47
  
In another approach, Liskamp and colleagues used azobenzene moieties in order to control mast cell 
degranulation. This cellular process is activated by the binding of two SH2 domains of the spleen 
tyrosine kinase Syk to ITAM (Immunoreceptor tyrosine-based activation motif). They synthesized 
several ITAM analogs introducing photoswitchable units of different lengths to modulate their biding 
to the SH2 domains upon UV irradiation. After isomerization of the shortest azobenzene linker to the 
cis conformation, the affinity decreased of 4-fold. They also demonstrated that in the case of mole-
cules smaller than the wild type ITAM, the cis and the trans isomers bind the SH2 domains in a mon-
ovalent or divalent manner respectively (Figure 1.9).
48
  
 
Figure 1.9. Schematic representation of Syk tSH2 switching between a divalent and a monovalent binding as a result of isom-
erization of short linkers. Figure modified from Kiul et al. 2009. Permission approved by Wiley (Copyright 2009).48  
Recently, the groups of Giralt and Gorostiza showed that clathrin-mediated endocytosis, which has a 
role in many cell processes such as cell signaling regulation and surface protein expression, can be 
modulated by UV light. They generated photoswitchable inhibitors of protein-protein interactions 
(PIPPIs) which bind AP2, a well-known protein involved in endocytic trafficking. They designed the 
binders based on the C-term of β-arrestin which interacts with AP2 thanks to an α-helix secondary 
structure. Based on this sequence, they synthesized peptides with different spacing between two 
cysteine residues and cyclized them with BSBCA I5 to regulate the helix content upon UV light irradi-
ation. They obtained peptides that presented higher inhibitory activity either in the trans or in the cis 
conformation depending on the format (i,i+11 and i,i+7). The Ki values are reported in table 1.1, 
entry 6.
49
 
 
 
 
 
Chapter 1. Introduction 
24 
 
Entry Scaffold 
Cyclic 
Peptide 
Target Binding/Inhibition 
1 
 
14 aa 
LTTF β-
finger 
binding 
motif 
α-1-
syntrophin 
Kd cis = 10.6 µM 
Kd trans = no binding 
2 
 
8 aa 
FTKT β-turn 
binding 
motif 
Somatotropin 
release-
inhibiting 
factor (SRIF) 
receptor 
Ki cis = 1 µM 
Ki trans = 2.6 µM 
3 
 
Bak72-
87(i+7) 
BaK 72-
87(i+11) 
Bid91-
111(i+4) 
Bcl-xL 
 
  Kd [nM]  
 
Bak72-
87(i+7) 
 
BaK 72-
87(i+11) 
 
Bid91- 
111(i+4) 
 
linear 134±16 328±19 117±48 
trans 825±157 21±1 1275±139 
cis 42±9 48±10 55±4 
 
4 
 
7 aa 
RGD binding 
motif 
αvβ3 Integrin 
Values not shown 
trans 50% stronger binding than cis 
5 
 
5 aa 
RGD binding 
motif 
PMMA 
surfaces 
cis = same as uncoated surface 
trans = 17% enhancement 
6 
 
i+11 aa 
(trans 
bound) 
i+7 aa (cis 
bound) 
 
AP2 
(β-adaptin) 
 
TL-1 
trans bound 
Ki 
TL-2 
cis bound 
Ki 
trans 8±1 240±150 
cis 31±3 19±0.3 
 
 
Table 1.1. Summary of Ki/Kd of the photoswitchable cyclic peptides inhibitors/binders before and after irradiation.  
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1.3 Directed evolution of photoswitchable peptides 
In vitro evolution of proteins and peptides is a powerful method for discovery and develop-
ment of biomolecules such as therapeutics, biosensors and catalysts.
50
 Rational drug design requires 
deep knowledge of the structure of the target protein and of their interaction partners. The binders 
have to be accurately designed since only few of them can be produced and tested.
51
 On the other 
hand combinatorial strategies allow the simultaneous screening of billions of compounds trough 
iterative cycles of selection and amplification.
52
 
Phage display technology is a revolutionary in vitro technique which allows the screening of 
large combinatorial polypeptide libraries for the selection of binders to virtually any target.
53
 Classi-
cally, the libraries are generated so that every phage particle displays on its surface one or several 
copies of different polypeptides fused to the coat protein. The library is subjected to iterative cycles 
of affinity selection against the target of interest and amplification of the isolated binders. The link-
age between genotype and phenotype consents the fast identification of the ligands by PCR amplifi-
cation and DNA sequencing (Figure 1.10).   
 
Figure 1.10. Phage display selection process. The phage library containing billions of different clones is panned against the 
immobilized target. The bound clones are eluted, amplified and subjected to the following cycle. Image modified from Ullman 
et al. 2011. Permission approved by Oxford University Press (Copyright 2011).54 
The most common strains of phage employed for display technologies are f1, M13 and fd. 
They infect gram negative bacteria from which they are secreted without causing their lysis. The 
genome of about 6.4 kbp is coded by single stranded DNA end encapsulated in a tubular structure 
constituted by five coat proteins: pIII, pVI, pVII, pVIII, pIX. Classically, pVIII and pIII are mainly used to 
display proteins. pVIII is the major coat protein and it is found in several thousands of copies per 
virion. However, to preserve its functionality, only short peptides (6-8 residues) can be fused to it. 
pIII is a minor coat protein and 3 to 5 copies are expressed at the tip of the phage particle. It is usual-
ly preferred since it allows the introduction of large inserts at its N-term and it is compatible with 
monovalent display.
55
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1.3.1 Selection of cyclic peptides by phage display 
 
Peptides offer an attractive format for the development of therapeutics. Peptide ligands 
evolved by phage display can bind with high affinity and selectivity to protein targets. Furthermore, 
peptides are accessible to chemical synthesis and due to their small size, they can diffuse into tis-
sues. It is generally preferred to develop cyclic rather than linear peptides for the following reasons. 
The cyclic format allows the formation of constrained structures with reduced entropy, higher bind-
ing affinity, selectivity and stability to proteolytic cleavage. The most common way of generating 
cyclic peptides on phage is to oxidize a pair of cysteines present in the sequence forming a disulfide 
bridge. Classically, the phage-encoded peptide libraries present the format CXnC, where the peptide 
contains n random amino acids (X) flanked by two cysteine residues (C). The format XlCXmCXn has 
also been widely used. In order to increase the number of interaction sites between the peptide and 
the target, several random positions can be inserted at both ends. For example libraries with the 
format XCX4,6,8CX were generated and screened for the binding to different monoclonal antibodies.
56
  
Peptides cyclized with one disulfide bridge could be isolated against a wide range of protein 
targets. However, most of these monocyclic peptides displayed rather weak binding affinities (mi-
cromolar range). Christian Heinis in collaboration with Sir Greg Winter had developed a method to 
screen libraries of bicyclic peptides by phage display.
53,57,58
 Linear peptides containing three cysteine 
residues spaced by random amino acids are cyclized using the linker tris-(bromomethyl)benzene 
(TBMB) (Figure 1.11). Compared to the monocyclic, the more rigid bicyclic format is expected to 
induce a higher binding affinity. Furthermore, in this peptide format, two peptide rings can interact 
with protein targets and the resulting affinity is higher. 
 
Figure 1.11. Cyclization of peptide containing three cysteine residues with tris-(bromomethyl)benzene. Image modified from 
Heinis et al. 2009. Permission approved by Nature Publishing Group (Copyright 2009).53 
1.3.2 Directed evolution of light-controlled peptides 
As described above, many of the photocontrolled protein and peptides described in litera-
ture were obtained by molecular design. Only recently, two strategies were developed for the in 
vitro evolution of photoswitchable peptide ligands and they will be described in the following two 
paragraphs. 
59,60
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Liu et al. proposed in 2012 a method for the selection of peptides containing non-natural 
photoswitchable amino acids using ribosome display.
60
 A tRNA carrying the amber anticodon was 
linked to an azobenzene-containing modified lysine residue and was mixed with mRNA encoding a 
peptide library to allow protein translation using the PURE SYSTEM technology. The library was incu-
bated with the model target streptavidin for half an hour and the non-binders were removed. In 
order to select for trans binders, the solution was irradiated with UV light to induce the isomeriza-
tion and therefore the release of the peptides binding in the cis form (Figure 1.12). The isolated 
clones were collected and sequenced after RT-PCR. 81 clones were identified. 
 
Figure 1.12. Ribosome display strategy for the selection of photoresponsive peptide aptamers reported by Liu et al 2012.  
 Only the sequences LA37 VLIMVAVXASS and LA40 HSCXVTIDVFF (where X indicates the 
modified lysine residue) were found several times. Additionally, five clones had incorporated two 
non-natural amino acids suggesting that they could show the largest conformational change. Pep-
tides LA81 (sequence GVTXRRFIXYV), LA37 and LA40 were synthesized with the FLAG sequence 
DYKDDDDKA and tested for binding to streptavidin with an anti-FLAG antibody in an ELISA assay. The 
fluorescence intensity in the ELISA assay dropped 50% after UV irradiation. Overall, the efficiency of 
the method was not well evaluated as the binding affinity of the isolated peptides was not reported. 
The change in binding observed in the ELISA assay in only moderate. 
Recently, the group of Derda reported the first example of phage selection of light-
responsive peptides. Their goal was to isolate ligands binding the protein target in trans confor-
mation and released after UV irradiation. A phage encoded library displaying heptamers flanked by 
cysteine residues (format CX7CA, diversity of 2x10
8
) was first reduced using immobilized TCEP and 
afterwards cyclized with the azobenzene reagent BSBCA.  Affinity selection was performed against 
the model target streptavidin. In a control experiment, the phage panning was carried out with un-
modified phage peptide. A scheme of the general selection strategy is reported in figure 1.13. 
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Figure 1.13. Phage display selection strategy applied by Derda et al. for the isolation of light-responsive cyclic peptides.59 
After three iterative rounds of selection 80 clones were sequenced and only 48 contained the insert. 
No consensus sequence was identified. The binding to streptavidin was measured by phage ELISA for 
the BSBCA-modified peptides, and in parallel for the disulfide cyclized peptides. Only three clones 
(P36, P42, P57) showed a significant affinity after BSBCA cyclization. To verify whether the binding of 
these ligands could be photo-modulated, they were subjected to an ESI-MS binding assay before and 
after UV irradiation. A peptide selected in the unmodified population presenting the streptavidin 
binding motif HPQ was also tested (P81). As additional control a peptide (P5) classified as “non-
binder” was tested too.  The table summarizing the Kd values is shown below (Table 1.2).   
S-S peptides BSBCA peptides 
peptide sequence Kd (μM) Kd 
dark (μM) Kd 
light (μM) ∆Kd 
P5 ACMSNKYSLCG ˃ 2000 ˃ 2000 ˃ 2000 N/A 
P36 ACGFERERTCG ˃ 2000 452±63 ˃ 2000 ˃ 4.5 
P42 ACLSQRDGNCG ˃ 2000 368±103 814±55 2.2 
P57 ACSVKLHTHCG ˃ 2000 506±89 1223±201 2.4 
P81 ACTSHQPRVCG 158±76 229±21 239±41 1.0 
Table 1.2. Table summarizing the Kd values determined by ESI-MS binding assay.
59
 
 
All the measured Kds were in the high micromolar range and the best ligands exhibited a 4.5-fold 
difference of affinity between the trans and the cis conformation. Overall, the binding affinities of 
the peptides were rather low. Previously, several groups had isolated disulfide cyclized peptides 
against streptavidin and the affinities of those peptides were nearly 1000-fold better. 
1.4 Streptavidin 
1.4.1 Structure and interaction with biotin 
Streptavidin is a tetrameric protein of 159 amino acids (molecular weight   ̴64kDa) which 
was first isolated in 1963 during a screening of new antibacterial molecules produced by Streptomy-
ces avidinii that are active against gram negative bacteria.
61
 Due to its highly specific and strong 
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binding affinity for the vitamin biotin (Kd  ̴10
-15
 M), this protein has been extensively used in molecu-
lar biology and chemistry.
62
 The most common applications include protein purification,
63
 diagnostic 
and immunological assays, microscopy, protein and nucleic acids detection.
64
 Its tetrameric structure 
can be considered as a dimer of dimers. Each streptavidin subunit is constituted by an eight-stranded 
antiparallel β barrel (Figure 1.14).
65
 Two monomers are associated tightly through van der Waals 
interactions and every pair of barrel is further organized in dimers weakly stabilized by hydrogen 
bonds and van der Waals interactions. 
66,67
 
 
Figure 1.14. Crystal structure of tetrameric streptavidin. PDB file 1NBX.65  
The binding of biotin to streptavidin has been characterized and studied by X-ray crystallography. 
The biotin binding pocket is localized in the dimer-dimer interface so that every tetramer can bind up 
to four biotin molecules. The ureido oxygen of biotin forms H-bonds with the residues Asn-23, Ser-27 
and Tyr-43, the ureido amino groups with Ser-45 and Asp-128, the sulfur with Thr-90 and the car-
boxyl group with Asn-49 and Ser-88. The thiophene ring and the alkyn chain establish van der Waals 
interactions with the hydrophobic part of the pocket composed by Trp-79, -92, -108, -120, Leu-25, 
Val-47, Leu-1 10 and by Trp-120 of the adjacent subunit (Figure 1.15).  
 
Figure 1.15.  i) X-ray structure of biotin in magenta bound to a subunits dimer in gray (left). ii) Biotin (magenta) bound to a 
streptavidin monomer (right). The residues forming H bonds are represented in green, the amino acids involved in hydropho-
bic interactions are shown in dark blue. PDB file 3RY2.65 
 
a b 
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1.4.2 Selection of peptidic streptavidin binders by phage display 
Classically, drug synthesis and development is based on the structure of the natural proteic 
binders. In the case of streptavidin, several studies have been performed using an opposite ap-
proach: the analysis and the characterization of its natural non-peptide ligand have been used as 
starting point for the development of peptide binders. The comparison of the mechanism with which 
two different molecules binds to the same pocket can indeed reveal important information applica-
ble to rational drug design.
68
  
Giebel et al. performed phage display selection against streptavidin using three cyclic pep-
tide libraries with the format CX4C, CX5C and CX6C. 
69
 It was shown that the disulfide bridge con-
strained peptides had a much higher binding affinity than the linear ones that are characterized by a 
high degree of flexibility and therefore elevated entropy.
68,69
 Many of the peptides identified as 
streptavidin binders showed the HPQ motif which is known to bind the biotin binding pocket. 
69,70
  
 
Figure 1.16. Crystal structure of peptide cyclo-Ac-CHPQFC-NH2 (orange) complexed with a streptavidin monomer. The protein 
residues involved in the formation of H bonds are represented in green. PDB file 1SLD.70   
Figure 1.16 shows the key streptavidin residues (Asn-23, Ser-27, Tyr-43, Ser-88, Thr-90, Asp-128) 
which establish hydrogen bonds with the peptide cyclo-Ac-CHPQFC-NH2. Crystallographic studies 
demonstrated that the Gln side chain of the HPQ sequence is partly superimposable to biotin. Fur-
thermore, the amino acids flanking the HPQ binding motif can increase the number of interactions 
playing a role in the binding.
70,71
 A second consensus (EPDW) was isolated using a phage display 
library of linear decapeptides.
71
 This motif shared similarities with a previously published streptavi-
din binder GDWVFI.
72,73
 A well-known tag used for protein purification called Strep-tag® (sequence 
AWRHPQFGG, Kd: 10
-5
 M) was also selected from a genetically encoded peptide library.
74,75
 Its se-
quence was further optimizes thank to crystallographic studies and rational design. Strep-tag II® 
(sequence: NWSHPQFEK) which binds Strep-Tactin® (a genetically modified streptavidin with higher 
binding capacity) with a Kd of 1 µM was obtained.
63
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1.5 Urokinase-type plasminogen activator (uPA) 
1.5.1 uPA structure and function 
Human uPA is a serine protease produced and secreted as a pro-enzyme, also called (sc) 
uPA (single chain uPA), a protein of 411 amino acids with low proteolytic activity (MW   ̴ 54 kDa). It is 
converted to its active form (tc) uPA (two-chain u-PA) through the proteolytic cleavage of the pep-
tide bond between Lys-158 and Ile-159. The two corresponding chain A (residues 1-158) and chain B 
(residues 159-411) are linked by a disulfide bridge (Cys-148 and Cys-279). Its active site is composed 
by the catalytic triad His-57, Asp-102, Ser-195 located in the chain B (Figure 1.17). The A chain of the 
tc form is further cleaved between the residues Lys-135 and Lys-136 originating a new truncated 
form called LMW-uPA (low molecular weight uPA).
76
 
 
Figure 1.17. X-ray structure of uPA catalytic triad His-57, Asp-102, Ser-195 (red) complexed with the inhibitor Glu-Gly-Arg 
chloromethyl ketone (cyan). PBD 1LMW.76 
uPA is involved in the plasminogen activation system. It binds to urokinase-type plasmino-
gen activator receptor in its zymogen form. Once uPA is activated, it cleaves plasminogen converting 
it to plasmin which mutually cleaves pro-uPA. Plasmin further participates to the degradation of the 
extra cellular matrix, fibrinolysis and activation of the matrix metalloproteinases cascade. This sys-
tem is negatively regulated by two uPA inhibitors, the serpins PAI1 and PAI2 and by α2-antiplasmin 
responsible for the inhibition of plasmin.
77
 Due to its essential function in tissue remodeling, it plays 
a crucial role in cell migration, proliferation and invasion. uPA was indeed found to be overexpressed 
in many pathologies such as inflammation and cancer becoming an interesting drug target.
78,79
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1.5.2 Selection of peptidic uPA inhibitors by phage display 
Numerous protein or peptide based inhibitors of uPA have been identified by phage display 
technology. The group of Dario Neri isolated an uPA inhibitor from an antibody phage display. Unfor-
tunately it did not show any effect in vivo, probably due to the low penetration rate into tumors 
tissues.
80
 Andreansen et al. selected from a phage-encoded peptide library upain-1, a disulfide 
bridge cyclic peptide of twelve amino acids which inhibits u-PA with a Ki of around 7 nM.
81
 UK18, a 
highly potent and selective bicyclic peptide inhibitor cyclized with 1,3,5-tris(bromomethyl)benzene 
(TBMB) was discovered in our laboratory (Ki = 53 nM). The crystal structure of the UK18-uPA com-
plex (Figure 1.18) revealed high similarities to protein-protein interaction: the peptide is constrained 
and it has a large contact interface stabilized by 14 H-bonds.
57
 The substitution of L-Ser with D-Gly 
improved its proteolytic stability 4-fold and its inhibitory activity 1.8-fold.
82
 
 
Figure 1.18. Bicyclic peptide inhibitor UK18 and crystal structure of its complex with uPA. Figure taken from Angelini et 
al.2012. Permission approved by American Chemical Society (Copyright 2012).57 
 
Recently, several lab members performed phage selection against uPA using different linkers such as 
1,3,5-triacryloyl-1,3,5-triazinane (TATA), and N,N’,N”-(benzene-1,3,5-triyl)tris(2-bromoacetamide) 
(TBAB) (Figure 1.19).  
 
Figure 1.19. Structure of TATA and TBAB. 
 
It was found that the use of different chemical linkers leads to the isolation of diverse consensus 
sequences and that their interaction with peptides stabilizes the conformation and promote the 
isolation of high affinity binders (Figure 1.20).
58
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Figure 1.20. Peptides isolated by phage selections against uPA from the XCX4CX4CX library after modification with the linkers 
TBMB (a), TATA (b), and TBAB (c). The consensus sequences are highlighted in colours. The figure is taken from Chen et al. 
2014. Permission approved by Wiley (Copyright 2014).58  
In another work, panning of a peptide library with the format XCX4CX4CX against uPA yielded many 
peptides with four cysteines (Figure 1.21). A study of the isolated peptides revealed that pairs of 
cysteines formed disulfide bridges. The peptides had thus bicyclic structures based on two disulfide 
bridges. 
83
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Figure 1.21. Phage selection of bicyclic peptides against u-PA. The peptides were isolated isolated from the XCX4CX4CX library 
cyclized either by oxidation (A) or by modification with TBMB (B). Consensus sequences are highlighted in colours. The figure 
is taken from Chen et al. 2013. Permission obtained from Amenican Chemical Society (Copyright 2013).83 
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 Synthesis and photo-Chapter 2
chemical properties of oligo-ortho-
azobenzenes  
 
This chapter is based on the following publication. Bellotto S., Reuter R., Heinis C., and Wegner H.A. 
Synthesis and photochemical properties of oligo-ortho-azobenzenes. J. Org. Chem. 2011, 76: 9826-
9834. Reprinted with permission from the American Chemical Society. Copyright 2011. 
 
2.1 Abstract 
Azobenzenes have attracted great interest in recent years due to their ability to change con-
formation upon irradiation. This property has been featured in several applications not only in organ-
ic chemistry but also in biology. Even though mono-azobenzenes have been extensively studied and 
documented in literature, only few methods are available for the synthesis of oligo-ortho-
azobenzenes. Also, their photochemical properties have not been reported so far. This study shows 
an efficient strategy for the preparation of oligo-ortho-azobenzenes and the investigation of their 
photochemical properties. It is demonstrated that the absorption spectra are highly influenced by 
the substituents. Interestingly, none of the ortho-bis-, tris- or tetra-azobenzene showed any E  Z 
isomerization. Only the ortho-nitrogen substituted mono-azobenzenes photochromic behavior upon 
UV irradiation was observed.  
2.2 Introduction 
Since their discovery in the nineteenth century, azocompounds have been extensively used 
as dyes and pigments.
1
 Therefore, several synthetic strategies have been developed to prepare azo-
benzene derivatives. Among all, the most relevant and common methods found in literature are the 
oxidation of anilines, reduction of nitro-substituted aromatic compounds, the Mills reaction
84
 (con-
densation of an aniline with a nitroso compound) and the diazo-coupling via diazonium salts.
85
 Re-
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cently, a new synthetic strategy was proposed, in which a Pd-catalyzed coupling reaction was em-
ployed.
86
 Additional to their use as colorants, a well-known property of azobenzenes is the pho-
toisomerization from the E to the Z isomer and back.
87
 The two isomers can be switched with ultra-
violet light. The more intense absorption at 320 nm corresponds to the π-π* (S2 state) transition and 
irradiation at this wavelength leads to E  Z isomerization, while the Z isomer absorbs at longer 
wavelength, around 430 nm which is due to the n-π* (S1 state) transition inducing Z  E isomeriza-
tion. Since the E isomer is more stable by approximately 50 kJ/mol, the Z isomer can also easily relax 
back via Z  E isomerization upon heating.
88
 Upon UV irradiation the distance between the para 
carbon atoms decreases from about 9.0 Å in the E isomer to 5.5 Å in the Z form.
89
 Thanks to this 
property, azo compounds have been employed for different uses and applications such as in light 
controlled polymers,
90
 liquid cristals,
91
 surfaces,
92
 catalysts
93
 and more recently resulted to be really 
promising in controlling the structural and functional changes in biomolecules. Azobenzene deriva-
tives, indeed, have been used for the photoswitching of proteins, like ion channels and receptors and 
for the photo-control of peptides,
34
 nucleic acids, lipids and carbohydrates.
3
  
Compounds containing isolated azobenzenes have been already thoroughly 
investigated;
5,94,95
 the interplay of multiple azobenzenes, however, has only been scarcely addressed. 
Bléger et al. investigated the photochromic and thermochromic behavior of four different para-
bis(azo) connected by biphenyls.
96
  Furthermore, the photochemical properties of a meta- and a 
para-bis(azo) derivative have been studied and compared. It has been shown that while the (E,E)-m-
bisazobenzene has a similar behavior to the (E)-azobenzene, the (E,E)-p-azobenzene presents a red 
shift in the absorption spectrum and a lower photoreactivity upon UV-irradiation.
97
 The correspond-
ing ortho-bis azobenzenes, though, have not been investigated so far. One explanation might be the 
difficulties in the preparation of these structural themes with the known methods, making their 
synthesis quite challenging. Only a few examples have been reported in the literature. At the end of 
the nineteenth century Mendola published a diazotization by sodium nitrite.
98
 The synthesis of or-
tho-bis-azobenzenes, performed by Mills reaction in acetic acid and sodium acetate was reported by 
Ruggli et al.
99-101
 More recently, in addition to the preparations previously published by our group,
87
 
the treatment of azoxybenzenes with sodium sulphide,
102
 or a diazotization with sodium nitrite
103
 
have also been described for their synthesis. Herein, we present an efficient strategy for the prepa-
ration of oligo-ortho-azobenzenes and show the influence of conjugated azobenzene units and sub-
stituents in ortho position on the photochemical properties. 
2.3 Results and discussion 
Even though several procedures are known for the synthesis of azobenzenes, none of them 
proved to be suitable for the preparation of ortho-nitrogen substitued azobenzenes. The oxidative 
coupling with manganese dioxide, potassium superoxide, the reductive coupling with zinc and sodi-
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um hydroxide, a Pd-catalyzed strategy and the Mills reaction were evaluated; none of them gave the 
expected product. For this reason a method previously developed in our group was used,
87
 in which 
the Mills reaction was modified using toluene as solvent and AcOH in stoichiometric amounts. Sev-
eral ortho-nitrogen-substituted azobenzenes have been synthesized using these optimized condi-
tions (Table 2.1). 
 
Entry R
1
 R
2
 T/ºC Product (Yield) 
1 NH2 NHAc 60 3a (70%) 
2 NH2 H 60 3b (33%) 
3 NH2 NO2 RT 3c (4%) 
4 H NO2 60 3d (24%) 
5 NO2 H 60 3e (n.r.) 
6 NO2 NO2 60 3f (n.r.) 
7 NHAc NHAc 60 3g (4%) 
8 NHAc NO2 60 3h (48%) 
9 NHAc H 60 3i (11%) 
10 H NHAc 60 3i (72%) 
 
Table 2.1. Synthesis of 2,2’-dinitrogen-substituted azobenzenes 3. 
The efficiency of the reactions was shown to be dependent on the substituents. The reaction of en-
try 3 (Table 2.1) proceeded at RT due to the electron withdrawing effect of the nitro group making 
the nitroso coupling partner 2 more reactive. However, 2-nitroaniline did not react either with nitro-
sobenzene (2b) (Table 2.1, entry 5) or 2-nitronitrosobenzene (2c) (Table 2.1, entry 6). Because of the 
presence of the nitro group in ortho position, the nucleophilicity of the amino group is greatly re-
duced towards an attack at the nitroso compound.  
In order to obtain ortho-bis-azobenzenes, 2-amino substituted azobenzenes 3a, 3b and 3l 
were subjected to the optimized Mills condition (AcOH, toluene). Interestingly, the classical condi-
tion (AcOH as solvent) gave in most cases superior results.   
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Entry R
1
 R
2
 T/ºC t Condition
a
 Product (Yield) 
1 NH2 NHAc 60  2,5 d B  4a (16%) 
2 NH2 H 60 21h B  4b (16%) 
3 NH2 NO2 RT 15 min A 4c (81%) 
4 H NO2 60  21h A 4d (17%) 
5 NHAc NHAc 6o 21h A 4e (44%) 
6 NHAc NO2 60 21h A 4f (66%) 
7 
 
NHAc H 60 
 
21h 
 
A 
C 
      4g (2%) 
 4g (44%) 
a
A: AcOH; B: toluene, AcOH (4 equiv), C: 2 (4 equiv), toluene, AcOH (4 equiv). 
Table 2.2. Synthesis of 2,2’’-dinitrogen-bis-substituted azobenzenes 4. 
The reactivity of the nitrosocompounds 2a, 2b and 2c was similar to the one observed for 
the 2-substitued-anilines influenced by the electron withdrawing or donating effect of the substitu-
ents. Indeed, thanks to the presence of the nitro group, the reaction of the diamine with 2-
nitronitrosobenzene (2c) (Table 2.2, entry 3), was completed after a few minutes at RT under classi-
cal Mills conditions, while the other products were only obtained after longer reaction times at 60°C. 
For example, when 2-nitrosoacetanilide (2a) was used, the reaction was completed after 2.5 days 
and the product was obtained in low yield (Table 2.2, entry 1). The reaction of entry 7 (Table 2.2) 
gave 2-phenylbenzotriazole as the main product. Only when four equiv of nitrosobenzene (2b) were 
used, the desired compound was obtained as the major product (Table 2.2, entry 7, condition C).  
The different reactivity of o-phenylenediamine (1a) and 2-amino substituted azobenzenes 
opens the possibility to obtain 2,2’’-dinitrogen- substituted -bisazobenzenes in a one-pot procedure. 
The method was shown to be efficient for the preparation of the non-symmetric 2,2”-di-substitued 
bis-ortho-azobenzenes. Indeed, compounds 4f and 4g were obtained in good to moderate yields 
starting from o-phenylenediamine (1a) (Scheme 2.1).  
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Scheme 2.1. One-pot preparation of non-symmetric 2,2”-di-substitued bis-ortho-azobenzenes. 
The same procedure was followed in the preparation of the symmetric 2,2”-di-substitued bis-ortho-
azobenzenes (Scheme 2.2). When nitrosobenzene (2b) and o-phenylenediamine (1a) were subjected 
to the modified Mills conditions, the product 4h was isolated after 3 days in 33% yield. However, the 
reaction with the 2-nitronitrosobenzene did not give the desired product.  
 
Scheme 2.2. One-pot preparation of the symmetric 2,2”-di-substitued bis-ortho-azobenzene 4h. 
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Unfortunately, the same protocol was not applicable for the synthesis of symmetric 2,2”’-di-
substitued tris-ortho-azobenzenes 5 (Scheme 2.3). 
 
Scheme 2.3. Attempted one-pot preparation of symmetric 2,2”-di-substitued tris-ortho-azobenzenes 5. 
Therefore, a stepwise approach was chosen to access 2,2’’’-di-substitued tris-ortho-
azobenzenes with different substituents (Scheme 2.4). The modified Mills reaction was found to be 
the best procedure. It was observed that the higher the number of the azobonds the longer is the 
reaction time. Indeed, the reaction required 8 days to provide the product in acceptable yield. The 
synthesis of the 2,2’’’’-di-substitued tetra-ortho-azobenzenes was performed only for the dinitro-
ortho-substituted 6. As expected from the reactivity previously observed, the reaction was finished 
after only 4 days. The product was obtained in a moderate yield (25%) compared to the tris-ortho-
azobenzenes 5a and 5b.         
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Scheme 2.4. Synthesis of non-symmetric 2,2”’-di-substitued tris-ortho-azobenzenes. 
Other non-symmetric 2,2”’-di-substitued tris-ortho-azobenzenes were synthesized accord-
ing to the strategy shown in Scheme 2.5 relying on the one-pot procedure to prepare the key inter-
mediate 3a. The deprotection of compound 4g gave the amino-substituted bisazobenzene 4b, fol-
lowed by Mills reaction. The coupling with 2-nitrosoacetanilide (2a) and nitrosobenzene (2b) did not 
provide any of the desired products. When 2-nitronitrosobenzene (2c) was used, the reaction oc-
curred and the corresponding tris-ortho-azobenzene 5c was obtained after 6 days in 21% yield. 
Again, this reactivity can be rationalized by the reduced electron density of the nitroso functionality 
due to the electron-withdrawing effect of the nitro group. 
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Scheme 2.5. Synthesis of non-symmetric 2,2’”-di-substitued tris-ortho-azobenzenes. 
Accordingly, a similar strategy gave 2-nitro-2’”-acetamido-tris-ortho-azobenzene 5f as pre-
sented in Scheme 2.6. The ortho-substituted diamine 3l was obtained by deprotection of 2-
acetamido-2’-aminoazobenzene (3a). The following two Mills reactions gave first compound 4a in 
59% and the final product 5f in 58% yield, respectively.  
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Scheme 2.6. Synthesis of 2-nitro-2’”-acetamido-tris-ortho-azobenzenes (5f). 
With all the different oligo-ortho-azobenzenes in hand, the photochemical properties were 
studied. The absorption spectra were acquired and the photoisomerization behavior was assessed. 
In particular, the influence of the conjugated systems and of the substituents was investigated. First, 
the absorption spectra of the ortho-nitrogen substituted mono-azo-benzenes were measured in 
chloroform. All of them showed the typical π-π* transition at around 320 nm. However, depending 
on the substituents, specific characteristics can be distinguished. In all the amino substituted azo-
benzenes, where a free NH2 group is present, the spectra present a broad peak at around 450 nm. 
The presence of the nitro group causes a slight bathochromic shift of the spectrum. This shift is also 
observed when the second substituent is an acetamido group or a free amino group. In the case 
where the nitro group is the only substituent, the spectrum is highly similar to the one of the azo-
benzene (Figure 2.1a). If all the acetamido substituted azobenzenes are compared, the presence of 
shoulders at around 400 nm is observed (Appendix, supporting information). 
All the ortho-nitrogen substituted mono-azobenzenes were irradiated at 365 nm (hand-held lamp, 8 
W) and the switching ability analysed by UV-spectroscopy (Figure 2.1b-d; Appendix, supporting in-
formation for details). Compound 3i followed the classical well known behavior of azobenzene (Fig-
ure 2.1d). Indeed, the absorbance increased at 450 nm and decreased at 320 nm until it reached the 
photostationary state after a few seconds of irradiation. It completely relaxed back after 2 h at RT. 
Compounds 3a , 3b (Figure 2.1b), 3c, 3d (Figure 2.1c), 3g, 3h and 3l after exposure to UV light, 
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showed a decrease in absorbance for both the Z and the E isomer (Appendix, supporting information 
for details). The photoisomerization was reversible even after several cycles of irradiation for all the 
mono-azobenzenes. Furthermore, all compounds except 3d (Figure 2.1c), showed a higher absorb-
ance then the initial state after incubation at RT, especially if kept in the dark (3c, 3g, 3h, 3l, Appen-
dix, supporting information) and could be completely converted back after exposure to visible light 
indicating a mixture of E and Z isomer in the photo-stationary state at these conditions. It was also 
shown that the presence of electron withdrawing groups caused only small changes in the absorb-
ance (compound 3d, Figure 2.1c, for compounds 3c and 3h Appendix, supporting information). Ban-
dara et al. have also demonstrated the influence of substituents on the photoswitching behavior of 
azobenzene compounds. They describe, that in their system, based on azo-(aminomethyl)pyridine 
compounds, the presence of electron-donating groups reduces the photoisomerization properties. 
Similarly to what we observed, they reported a decreased absorbance for both E and Z isomer upon 
UV irradiation.
104
 This behavior is unusual, since the Z isomer of azobenzene normally shows an in-
creased intensity for the n−π* transition. Consequently a photochemical E → Z isomerization is ob-
served after irradiation with visible light, whereas for most azobenzenes a Z → E isomerization takes 
place if irradiated at 450 nm. 
 
 
Figure 2.1. Absorption spectra (Figure 2.1a) and photoisomerization of a representative ortho-amino, nitro and acetamido 
substituted mono-azobenzenes (3b, 3d, 3i respectively, Figure 2.1b-d) in chloroform. 
Chapter 2. Synthesis and photochemical properties of oligo-ortho-azobenzenes 
45 
 
The absorption spectra of the bis-ortho-azobenzenes showed a similar behavior as for the 
monoazobenzenes (Figure 2.2). Indeed, as previously described, the nitro group caused a small shift 
in the spectra, while the presence of the amino group was easily detectable due to the broad and 
high absorbance at around 450 nm. Once again, the acetamido-substituted compounds showed the 
typical pattern with three maxima at 340 nm, 400 nm and 470 nm. Furthermore, close to the π-π* 
transition at around 350 nm an additional shoulder can be noticed which is present in all bis-ortho-
azobenzenes. In the case of the di-amino substituted derivative 4i and 2-nitro-2’’’acetamido-
bisazobenzene (4f) (Appendix, supporting information) only a broadening of the absorption can be 
seen. 
In contrast to the switching behavior observed for mono-azobenzenes, none of bis-ortho-
azobenzenes switched upon UV-irradiation. Cisnetti and co-workers have demonstrated that (E,E)-m-
bisazobenzene behave similarly to azobenzene and that (E,E)-p-bisazobenzene also isomerizes alt-
hough a decreased photoreactivity has been observed
97
. The authors explain this fact by the larger 
electronic coupling in the p-bisazobenzene compared to the m-bisazobenzene, which they confirmed 
by quantum chemical calculations. If this increased electronic communication is the reason for the 
reduced isomerization, o-bisazobenzenes should exhibit an even lower isomerization tendency. In-
deed, in our case, all the tested compounds showed complete inertness toward photoisomerization. 
One possible alternative explanation would be that the back-isomerization is faster than the mini-
mum time required for the measurement (5 s). Flash photolysis studies have not been done so far to 
rule out this option. 
 
 
Figure 2.2. Absorption spectra of a representative ortho-amino, nitro, acetamido and hydrogen substituted bis-azobenzenes 
(4b, 4d, 4g and 4h respectively) in chloroform. 
 
An analog behavior was also observed for the tris and tetra-azobenzenes (Figure 2.3). The 
amino group causes also in these cases an increased absorbance at around 450 nm. The additional 
absorption caused by the acetamido group is less evident. The spectrum of tetra-azobenzene 6 is 
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comparable to the one of 4d and 5c due to the presence of the nitro groups. None of these com-
pounds shows isomerization upon-UV irradiation as it was previously observed for the bis-ortho-
azobenzenes. 
 
 
Figure 2.3. Absorption spectra of the di-substitued tris and tetra-ortho-azobenzenes in chloroform. 
2.4 Conclusions 
A stepwise convenient strategy for the preparation of oligo-ortho-azobenzenes and a one-
pot procedure for the synthesis of bis-ortho-azobenzenes have been presented. The photochemical 
properties of these compounds have been thoroughly investigated. It has been shown that the ab-
sorption spectra exhibit common features depending on the substituent. Additionally, only the or-
tho-nitrogen substituted mono-azobenzenes isomerized upon UV irradiation. Furthermore, the pres-
ence of electron-withdrawing groups induced a decreased photochromism. Current efforts in the 
group address the reason for the inhibition of the photochromism by substitution with another azo-
benzene moiety in ortho position. 
2.5 Experimental section 
2-Nitrosoacetanilide (2a). A solution of o-phenylenediamine (1a) (10.0 g, 92.5 mmol, 1.00 
equiv) in 150 ml EtOAc was cooled down below 5 °C. Then, an ice-cold solution of acetic anhydride 
(9.12 ml, 97.1 mmol, 1.05 equiv) in 80 ml EtOAc was added and stirred for 20 min. The precipitate 
that was obtained was filtered with a glass filter under vacuum to give 5.13 g (37%) of 2-
aminoacetanilide. 
1
H NMR (400 MHz, CDCl3) δ 9.10 (s, 1H), 7.15 (dd, J = 7.8, 1.2 Hz, 1H), 6.92 – 6.85 
(m, 1H), 6.70 (dd, J = 8.0, 1.3 Hz, 1H), 6.53 (td, J = 7.6, 1.4 Hz, 1H), 4.84 (s, 2H), 2.03 (s, 3H). The ana-
lytical data correspond to literature.
105
 The acetylated diamine (5.00 g, 33.3 mmol, 1.00 equiv) was 
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suspended in 50 ml CH2Cl2. Oxone
®
 (30.7 g, 49.9 mmol, 1.50 equiv), dissolved in 200 ml water, was 
added and stirred fiercely for 1h at RT. The organic phase was separated and the aqueous phase 
extracted with 100 ml CH2Cl2. The combined organic phases were washed with 1 M HCl (100 ml), sat. 
aq NaHCO3 (100 ml) and water (100 ml). It was then dried over MgSO4, concentrated and purified by 
flash column chromatography (SiO2, hexane/EtOAc, 2:1) and the product was obtained as green solid 
(2.41 g, 44% yield). Mp = 107–108 °C. (lit. Mp 106-107 ºC).
106
 
1
H NMR (400 MHz, CDCl3) δ  10.79 (s, 
1H), 8.85 (dd, J = 8.6, 1.0 Hz, 1H), 7.71 (ddd, J = 8.5, 7.2, 1.4 Hz, 1H), 7.32 (s, 1H), 7.22 – 7.08 (m, 1H), 
2.35 (s, 3H). The analytical data correspond to literature.
87
  
 
2-Nitronitrosobenzene (2c). Oxone
®
 (20.0 g, 32.6 mmol, 1.50 equiv) was treated with 24 ml 
of concentrated H2SO4. The suspension was then poured onto 130 g of crushed ice, and the mixture 
was stirred at RT until all of the ice has melted. Then, 2-nitroaniline (3.00 g, 21.7 mmol, 1.00 equiv) 
was added and stirred at RT for 20 h. The mixture was extracted twice with 150 ml of CH2Cl2, dried 
over MgSO4, the solvent removed and the titled compound was obtained as a brown solid (3.12 g, 
94%). Mp: 119–122 °C (lit. 135–137 °C).
107
 
1
H-NMR (400 MHz CDCl3) δ 8.17 (d, J = 8.0 Hz, 1H), 7.96 (t,
 
J = 8.0 Hz, 1H), 7.77 (t,
 
J = 8.0 Hz, 1H), 6.63 (d,
 
J = 8.0 Hz, 1H). The compound 2c is in equilibrium with 
its dimer and the analytical data correspond to literature.
108
  
General procedure for the Mills reaction using AcOH (condition A). A solution of amine  
(1.00 equiv) in acetic acid (7 ml/mmol) was degassed with a nitrogen stream for 15 min. Then, the 
nitroso compound 2 (1.00 equiv) was added. The mixture was stirred at 60 °C for 21 h and the sol-
vent was removed under reduced pressure. The residue was purified by flash column chromatog-
raphy.  
General procedure for the Mills reaction using AcOH/toluene (condition B). A solution of 
amine (1.00 equiv) in toluene (7 ml/mmol) was degassed with a nitrogen stream for 15 min. Then, 
the nitroso compound  (1.00 equiv) and acetic acid (4.00 equiv) were added. The mixture was stirred 
at 60 °C for 21 h and the solvent was removed under reduced pressure. The residue was purified by 
flash column chromatography.  
General procedure for the Mills reaction using AcOH/toluene (condition C). A solution of 
amine (1.00 equiv) in toluene (7 ml/mmol) was degassed with a nitrogen stream for 15 min. Then, 
the nitroso compound  (4.00 equiv) and acetic acid (4.00 equiv) were added. The mixture was stirred 
at 60 °C for 21 h and the solvent was removed under reduced pressure. The residue was purified by 
flash column chromatography.  
2-Acetamido-2’-amino-ortho-azobenzene (3a). The title compound 3a was prepared ac-
cording to general procedure (condition B) from o-phenylenediamine (1a) (0.821 g, 7.58 mmol, 1.00 
equiv) and 2-nitrosoacetanilide (2a) (1.25 g, 7.71 mmol, 1.00 equiv). The residue was purified by 
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flash column chromatography (SiO2, hexane/EtOAc, 1:1) and the title compound was obtained as red 
solid in 70% yield (1.35 g). Mp 148–150 °C (lit. 143 °C);
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1
H NMR (400 MHz, CDCl3) δ 9.95 (s, 1H), 
8.63 (d, J = 8.3 Hz, 1H), 7.70 (dd, J = 8.1, 1.6 Hz, 1H), 7.62 (dd, J = 8.1, 1.3 Hz, 1H), 7.45 – 7.37 (m, 1H), 
7.29 – 7.22 (m, 1H), 7.18 – 7.10 (m, 1H), 6.87 – 6.71 (m, 2H), 5.40 (s, 2H), 2.27 (s, 3H); 
13
C NMR (101 
MHz, CDCl3) δ 168.6, 145.0, 137.5, 135.5, 133.2, 131.8, 124.4, 123.5, 122.2, 120.5, 120.2, 118.0, 
117.4, 25.5. 
2-Amino-ortho-azobenzene (3b). The title compound 3b was prepared according to general 
procedure (condition B) from o-phenylenediamine (1a) (0.820 g, 7.58 mmol, 1.00 equiv) and nitro-
sobenzene (2b) (812 mg, 7.58 mmol, 1.00 equiv). The residue was purified by flash column chroma-
tography (SiO2, hexane/EtOAc, 7:1) and the title compound was obtained as brown solid in 33% yield 
(498 mg). Mp 58–62 °C; 
1
H NMR (400 MHz, CDCl3) δ 7.87 – 7.82 (m, 3H), 7.53 – 7.47 (m, 2H), 7.45 – 
7.39 (m, 1H), 7.22 (ddd, J = 8.5, 7.1, 1.6 Hz, 1H), 6.83 (ddd, J = 8.2, 7.1, 1.3 Hz, 1H), 6.77 (dd, J = 8.2, 
1.1 Hz, 1H), 5.90 (s, 2H). The analytical data correspond to literature.
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2-Amino-2’-nitro-ortho-azobenzene (3c). The title compound 3c was prepared according to 
general procedure (condition B) from o-phenylenediamine (1a) (0.820 g, 7.58 mmol, 1.00 equiv) and 
2-nitronitrosobenzene (2c) (1.15 g, 7.58 mmol, 1.00 equiv). The residue was purified by flash column 
chromatography (SiO2, hexane/EtOAc, 2:1) followed by preparative TLC (SiO2, hexane/CHCl3, 1:1) and 
the title compound was obtained as brown solid in 4% yield (73.2 mg). Mp 95-97 °C; 
1
H NMR (400 
MHz, DMSO) δ 8.05 (dd, J = 8.1, 1.2 Hz, 1H), 7.92 (dd, J = 8.1, 1.2 Hz, 1H), 7.84 – 7.76 (m, 1H), 7.68 – 
7.60 (m, 2H), 7.36 (s, 2H), 7.26 (ddd, J = 8.4, 6.9, 1.6 Hz, 1H), 6.88 (dd, J = 8.4, 1.0 Hz, 1H), 6.69 (ddd, J 
= 8.2, 6.9, 1.2 Hz, 1H); 
13
C NMR (101 MHz, DMSO) δ 146.7, 145.0, 144.2, 135.9, 134.1, 133.4, 130.0, 
127.7, 124.1, 118.0, 117.4, 115.9; MS (EI, 70 eV): m/z (%) = 242 (57%) [M
+
], 92 (100%); C12H10N4O2 
(242.24): calcd C 59.50, H 4.16, N 23.13; found C 59.35, H 4.14, N 22.88. 
2-Nitro-ortho-azobenzene (3d). The title compound 3d was prepared according to general 
procedure (condition B) from aniline (0.827 ml, 9.07 mmol, 1.00 equiv) and 2-nitronitrosobenzene 
(2c) (0.138 g, 0.907 mmol, 1.00 equiv). The residue was purified by flash column chromatography 
(SiO2, hexane/EtOAc, 3:1) and the title compound was obtained as orange-brown solid in 24% yield 
(502 mg). Mp 66–70 °C (lit. 67–68 °C);
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1
H NMR (400 MHz, CDCl3) δ 7.98 – 7.89 (m, 3H), 7.72 – 7.65 
(m, 2H), 7.62 – 7.49 (m, 4H); 
13
C NMR (101 MHz, CDCl3) δ 152.6, 147.6, 145.6, 133.2, 132.4, 130.6, 
129.4 (2C), 124.2, 123.8 (2C), 118.6. 
 
2,2’-Diacetamido-ortho-azobenzene (3g). The title compound 3g was prepared according to 
general procedure (condition B) from N-(2-aminophenyl)acetamide (495 mg, 3.30 mmol, 1.00 equiv) 
and 2-nitrosoacetanilide (2a) (541 g, 3.30 mmol, 1.00 equiv). The residue was purified by flash col-
umn chromatography (SiO2, DCM/EtOAc, 1:1) and 41.3 mg of orange product were obtained (4% 
yield). Mp 273–275 °C;
 1
H NMR (400 MHz, CDCl3) δ 9.38 (s, 2H), 8.68 (d, J = 8.4 Hz, 2H), 7.64 (d, J = 
Chapter 2. Synthesis and photochemical properties of oligo-ortho-azobenzenes 
49 
 
8.1 Hz, 2H), 7.52 (t, J = 7.8 Hz, 2H), 7.17 (t, J = 7.7 Hz, 2H), 2.30 (s, 6H). The analytical data correspond 
to literature.
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2-Acetamido-2’nitro-ortho-azobenzene (3h). The title compound 3h was prepared accord-
ing to general procedure (condition B) from N-(2-aminophenyl)acetamide (500 mg, 3.31 mmol, 1.00 
equiv) and 2-nitronitrosobenzene (2c) (506 mg, 3.33 mmol, 1.00 equiv). The residue was purified by 
flash column chromatography (SiO2, hexane/EtOAc, 1:1). The solvent was evaporated and the orange 
product was obtained in 48% yield (449 mg). Mp 143–147 °C; 
1
H NMR (400 MHz, CDCl3) δ 10.27 (s, 
1H), 8.74 (d, J = 8.5 Hz, 1H), 7.93 (dd, J = 8.0, 1.4 Hz, 2H), 7.81 (dd, J = 8.0, 1.5 Hz, 1H), 7.74 (td, J = 
7.7, 1.4 Hz, 1H), 7.61 (ddd, J = 8.0, 7.4, 1.5 Hz, 1H), 7.57 – 7.47 (m, 1H), 7.22 (ddd, J = 8.6, 7.3, 1.3 Hz, 
1H), 2.30 (s, 3H); 
13
C NMR (101 MHz, CDCl3) δ 167.0, 146.2, 144.8, 138.9, 135.0, 134.6, 133.4, 130.9, 
126.7, 124.5, 123.6, 120.9, 120.3, 25.4; MS (EI, 70 eV): m/z (%) = 284 (48%) [M
+
], 134 (100%); 
C14H12N4O3 (284.27): calcd C 59.15, H 4.25, N 19.71; found C 59.09, H 4.25, N 19.85. 
2-Acetamido-ortho-azobenzene (3i). The title compound 3i was prepared according to gen-
eral procedure (condition B) from aniline (0.294 ml, 3.22 mmol, 1.00 equiv) and 2-nitrosoacetanilide 
(2a) (529 mg, 3.22 mmol, 1.00 equiv). The residue was purified by flash column chromatography 
(SiO2, hexane/EtOAc, 1:1) and 555 mg  of yellow product were obtained (72% yield). The same prod-
uct was also prepared according to general procedure (condition B) from 2-acetamido-2’-amino-
ortho-azobenzene (3a) (470 mg, 3.13 mmol, 1.00 equiv) and nitrosobenzene (2b) (357 mg, 3.33 
mmol, 1.07 equiv). The residue was purified by flash column chromatography (SiO2, hexane/EtOAc, 
2:1) and 80.1 mg of yellow product were obtained (11 %). Mp 124–127 °C (lit. 127–129 °C);
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1
H 
NMR (400 MHz, CDCl3) δ 10.12 (s, 1H), 8.68 (d, J = 8.4 Hz, 1H), 7.91 – 7.81 (m, 3H), 7.58 – 7.50 (m, 
3H), 7.50 – 7.45 (m, 1H), 7.21 – 7.14 (m, 1H), 2.28 (s, 3H);
 13
C NMR (101 MHz, CDCl3) δ 168.7, 152.5, 
138.9, 136.1, 133.1, 132.0, 129.5 (2C), 123.5, 122.8 (2C), 121.3, 120.4, 25.5.  
2,2’-Diamino-ortho-azobenzene (3l). A solution of o-phenylenediamine (1a) (0.764 g, 7.07 
mmol, 1.00 equiv) in toluene (50 ml) was degassed with a nitrogen stream for 15 min. Then, 2-
nitrosoacetamide (1.16 g, 7.07 mmol, 1.00 equiv) and acetic acid (1.62 ml) were added. The mixture 
was stirred at 60 °C for 21 h and the solvent was removed under reduced pressure. The residue was 
purified by flash column chromatography (SiO2, hexane/EtOAc, 2:1) and the compound 3a was ob-
tained as red solid (0.792 g, 44% yield). Then, a solution of 2-acetamido-2’-amino-ortho-azobenzene 
(3a) (740 mg, 2.91 mmol) in ethanol (138 ml) was treated with a solution of KOH (12.1 g) in ethanol 
(80 ml) and water (32 ml). The mixture was heated to 90°C. After 1 h the mixture was poured onto of 
ice (500 g), extracted with CH2Cl2 (3x100 ml). It was dried over Na2SO4  and concentrated to yield 
0.583 g (94%). Mp 136-138 °C; 
1
H NMR (400 MHz, CDCl3) δ 7.68 (dd, J = 8.0, 1.4 Hz, 2H), 7.21 – 7.14 
(m, 2H), 6.83 – 6.74 (m, 4H), 5.49 (s, 4H). The analytical data correspond to literature.
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2-Acetamido-2’’-amino-ortho-bisazobenzene (4a). The title compound 4a was prepared ac-
cording to general procedure (condition B) from 2,2’-diaminodiazobenzene (3l) (300 mg, 1.41 mmol, 
1.00 equiv) and 2-nitrosoacetanilide (2a) (230 mg, 1.41 mmol, 1.00 equiv). After 2.5 days the solvent 
was removed under reduced pressure and the residue was purified by flash column chromatography 
(SiO2, hexane/EtOAc, 2:1). The product was obtained as a red solid (80.3 mg, 16%). Mp 158–162 °C; 
1
H NMR (400 MHz, CDCl3) δ  10.12 (s, 1H), 8.69 (d, J = 8.3 Hz, 1H), 7.88 (dd, J = 8.1, 1.5 Hz, 1H), 7.85 
(dd, J = 8.1, 1.5 Hz, 1H), 7.81 (dd, J = 7.9, 1.5 Hz, 1H), 7.72 (dd, J = 7.7, 1.6 Hz, 1H), 7.62 – 7.44 (m, 
3H), 7.20 (ddd, J = 15.3, 8.4, 1.4 Hz, 2H), 6.87 – 6.81 (m, 1H), 6.74 (dd, J = 8.2, 1.0 Hz, 1H), 6.31 (s, 
2H), 2.00 (s, 3H). The analytical data correspond to literature.
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2-Amino-ortho-bisazobenzene (4b). The title compound 4b was prepared according to gen-
eral procedure (condition B) from 2,2’-diaminodiazobenzene (3l) (0.250 g, 1.19 mmol, 1.00 equiv) 
and nitrosobenzene (2b) (0.130 mg, 1.19 mmol, 1.00 equiv). The residue was purified by flash col-
umn chromatography (SiO2, hexane/EtOAc, 7:1). The product was obtained as a brown solid (51.3 
mg, 16%). Mp 97–100 °C; 
1
H NMR (400 MHz, CDCl3) δ 7.97 (dd, J = 8.0, 1.6 Hz, 1H), 7.95 – 7.88 (m, 
3H), 7.76 (dd, J = 8.0, 1.4 Hz, 1H), 7.62 – 7.45 (m, 5H), 7.21 (ddd, J = 8.5, 7.1, 1.6 Hz, 1H), 6.86 (ddd, J 
= 8.2, 7.1, 1.3 Hz, 1H), 6.74 (dd, J = 8.3, 1.1 Hz, 1H), 6.69 (s, 2H); 
13
C NMR (101 MHz, CDCl3) δ 153.3, 
148.1, 147.9, 141.5, 138.0, 133.2, 132.3, 131.7, 131.4, 130.4, 129.3 (2C), 123.3 (2C), 117.3, 117.2, 
117.1, 116.4; HRMS (ESI): m/z calcd for C18H15N5
+
 [M+H
+
] 302.1406, found 302.1400. 
2-Amino-2’’-nitro-ortho-bisazobenzene (4c). To a round bottom flask was added the 2,2’- 
diaminoazobenzene (3l) (80.0 mg, 0.377 mmol, 1.00 equiv) and 2-nitronitrosobenzene (2c) (57.3 mg, 
0.377 mmol, 1.00 equiv) followed by AcOH (11 ml). The mixture was stirred for 15 min. Then, water 
was added (50 ml/mmol) and the liquid was carefully turned basic with sodium carbonate (2 M 
Na2CO3 in H2O, 5 ml/1ml AcOH). The mixture was then extracted with CH2Cl2 (3x20 ml/mmol), dried 
over MgSO4 and the solvent was removed. The residual black solid was re-suspended in CH2Cl2 and 
purified by flash column chromatography (SiO2, DCM/hexane 1:1). The product was obtained as a 
brown solid (106 mg, 81%). Mp 111–113 °C; 
1
H NMR (400 MHz, CDCl3) δ 7.97 (d, J = 7.0 Hz, 2H), 7.91 
(d, J = 8.1 Hz, 1H), 7.77 (d, J = 8.1 Hz, 1H), 7.72 – 7.67 (m, 1H), 7.64 (t, J = 7.6 Hz, 1H), 7.62 – 7.56 (m, 
2H), 7.51 (t, J = 7.6 Hz, 1H), 7.22 (d, J = 6.9 Hz, 1H), 6.87 (dd, J = 8.1, 7.0 Hz, 1H), 6.75 (d, J = 8.3 Hz, 
1H), 6.62 (s, 2H); 
13
C NMR (101 MHz, CDCl3) δ 149.0, 147.7, 147.4, 146.2, 141.7, 138.0, 133.3, 133.1, 
133.0, 132.6, 130.6, 130.4, 124.3, 119.0, 117.31, 117.30, 117.26, 117.0; HRMS (ESI): m/z calcd for 
C18H15N6O2
+
 [M+H
+
] 347.1251, found 347.1260. 
2-Nitro-ortho-bisazobenzene (4d). The title compound 4d was prepared according to gen-
eral procedure (condition A) from 2-amino-ortho-azobenzene (3b) (200 mg, 1.01 mmol, 1.00 equiv) 
and 2-nitronitrosobenzene (2c) (154 mg, 1.01 mmol, 1.00 equiv).  The mixture was stirred for 21 h at 
60 °C. The solvent was removed under reduced pressure and HCl (1 M aq. sol; 25 ml) was added. The 
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mixture was then extracted with CH2Cl2 (2x30 ml) and purified by flash column chromatography 
(SiO2, hexane/EtOAc,  7:1). An oily orange solution was obtained (57.2 mg) in 17% yield. Mp 61–65 
°C; 
1
H NMR (400 MHz, CDCl3) δ 8.01 – 7.97 (m, 2H), 7.97 – 7.93 (m, 1H), 7.83 – 7.78 (m, 1H), 7.76 (dd, 
J = 7.9, 1.4 Hz, 1H), 7.69 (dd, J = 5.2, 2.0 Hz, 2H), 7.67 – 7.61 (m, 1H), 7.61 – 7.50 (m, 5H); 
13
C NMR 
(101 MHz, CDCl3) δ 153.1, 149.2, 147.6 (2C), 146.0, 133.3, 132.5, 131.7, 131.2, 130.7, 129.3 (2C), 
124.3, 123.5 (2C), 119.11, 119.09, 117.9; HRMS (ESI): m/z calcd for C18H14N5O2
+
 [M+H
+
] 332.1142, 
found 332.1148. 
2,2’’-Diacetamido-ortho-bisazobenzene (4e). The title compound 4e was prepared accord-
ing to general procedure (condition A) from 2-acetamido-2’-amino-ortho-azobenzene (3a) (187 mg, 
0.735 mmol, 1.00 equiv) and 2-nitrosoacetanilide (2a) (123 mg, 0.749 mmol, 1.02 equiv). The residue 
was purified by flash column chromatography (SiO2, hexane/EtOAc, 1:2) and 130 mg of product were 
obtained (44%).  Mp 182–184 °C; 
1
H NMR (400 MHz, CDCl3) δ 10.04 (s, 2H), 8.69 (d, J = 8.3 Hz, 2H), 
7.86 (dd, J = 8.1, 1.4 Hz, 2H), 7.76 (dd, J = 6.0, 3.4 Hz, 2H), 7.65 (dd, J = 6.0, 3.4 Hz, 2H), 7.51 (t, J = 7.8 
Hz, 2H), 7.18 (t, J = 7.7 Hz, 2H), 1.91 (s, 6H). The analytical data correspond to literature.
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2-Acetamido-2’’-nitro-ortho-bisazobenzene (4f). The title compound 4f was prepared ac-
cording to general procedure (condition A) from 2-acetamido-2’-amino-ortho-azobenzene (3a) 
(0.101 g, 0.393 mol, 1.00 equiv) and 2-nitronitrosobenzene (2c) (59.8 mg, 393 mmol, 1.00 equiv). The 
residue was purified by flash column chromatography (SiO2, hexane/EtOAc, 2:1) and 103 mg of or-
ange product were obtained (66%).  Mp 136–138 °C; 
1
H NMR (400 MHz, DMSO) δ 10.19 (s, 1H), 8.32 
– 8.27 (m, 1H), 8.15 (dd, J = 7.8, 1.5 Hz, 1H), 8.01 (dd, J = 8.0, 1.3 Hz, 1H), 7.88 – 7.71 (m, 5H), 7.66 
(dd, J = 7.8, 1.5 Hz, 1H), 7.62 (dd, J = 8.0, 1.3 Hz, 1H), 7.59 – 7.53 (m, 1H), 7.27 – 7.20 (m, 1H), 1.97 (s, 
3H); 
13
C NMR (101 MHz, CDCl3) δ 169.4, 148.8, 147.3, 147.1, 146.1, 139.4, 134.8, 133.6, 133.4, 132.8, 
131.5, 130.1, 126.2, 124.4, 123.5, 120.6, 119.1, 118.8, 117.8, 25.2; MS (EI, 70 eV): m/z (%) = 388 
(51%) [M
+
], 106 (100%); C20H16N6O3 (388.39): calcd C 61.85, H 4.15, N 21.64; found C 61.46, H 4.17, N 
21.50. 
2-Acetamido-ortho-bisazobenzene (4g). The title compound 4g was prepared according to 
general procedure (condition C) from 2-acetamido-2’-amino-ortho-azobenzene (3a) (195 mg, 767 
mmol, 1.00 equiv) and nitrosobenzene (2b) (337 mg, 3.15 mmol, 4.00 equiv). After 3 h the reaction 
was finished and the solvent was removed under reduced pressure. The residue was purified by flash 
column chromatography (SiO2,hexane/EtOAc, 1:1) and 116 mg (44%) of orange product were ob-
tained. Mp 112–113 °C; 
1
H NMR (400 MHz, CDCl3) δ 10.49 (s, 1H), 8.70 (dd, J = 8.4, 1.1 Hz, 1H), 7.99 
(dd, J = 8.1, 1.6 Hz, 1H), 7.92 – 7.87 (m, 2H), 7.85 (dd, J = 7.8, 1.6 Hz, 1H), 7.71 (dd, J = 7.7, 1.7 Hz, 
1H), 7.61 (dqd, J = 14.8, 7.3, 1.6 Hz, 2H), 7.55 – 7.45 (m, 4H), 7.25 – 7.19 (m, 1H), 1.72 (s, 3H); 
13
C 
NMR (101 MHz, CDCl3) δ 169.4, 153.0, 149.7, 148.1, 147.1, 139.4, 135.2, 133.3, 131.8, 131.2, 129.4 
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(2C), 125.1, 123.4, 123.3 (2C), 120.6, 120.2, 118.0, 25.0; MS (EI, 70 eV): m/z (%) = 343 (83%) [M
+
], 
106 (100%). C20H17N5O (343.39): calcd C 69.96, H 4.99, N 20.40; found C 69.84, H 4.96, N 20.42. 
2,2’’-Diamino-bis-ortho-azobenzene (4i). A solution of 2,2’’-diacetamido-ortho-
bisazobenzene (4e) (3.76 g, 9.39 mmol, 1.00 equiv) in ethanol (341 ml) was treated with a solution of 
KOH (30.4 g, 542 mmol, 57.7 equiv) in ethanol (200 ml) and water (77 ml). The mixture was heated 
to 90 °C. After 1.5 h, the mixture was poured onto of ice (1.20 kg), extracted with CH2Cl2 (3x200 ml), 
dried over Na2SO4 and concentrated to yield a red oil (2.96 g), which crystallized in the refrigerator 
overnight (99 %). Mp: 95–98 °C. 
1
H NMR (400 MHz, CDCl3) δ 7.88 (dd, J = 8.1, 1.5 Hz, 2H), 7.81 – 7.75 
(m, 2H), 7.53 – 7.46 (m, 2H), 7.21 (ddd, J = 8.4, 7.1, 1.6 Hz, 2H), 6.87 – 6.81 (m, 2H), 6.75 (dt, J = 8.2, 
3.9 Hz, 2H), 6.27 (s, 4H). The analytical data correspond to literature.
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One-pot preparation of symmetric 2,2”-di-substitued bis-ortho-azobenzenes (4h). A solu-
tion of ortho-phenylendiamine (1a) (200 mg, 1.85 mmol, 1.00 equiv) in toluene (36 ml) was degassed 
with a nitrogen stream for 15 min. Then, nitrosobenzene (2b) (594 mg, 5.55 mmol, 3.00 equiv) and 
AcOH (215 μl, 3.75 mmol, 2.00 equiv) were added. The mixture was stirred at 60 °C for 18 h and 
more AcOH (108 ml) was added. After 2 days the solvent was removed under reduced pressure. The 
residue was purified by flash column chromatography (SiO2, hexane/EtOAc, 7:1) and the solid that 
was obtained was recrystallized from EtOH to obtain 177 mg of a brown solid (33%). Mp: 106–109 
°C; 
1
H NMR (400 MHz, CDCl3) δ 8.01 – 7.94 (m, 4H), 7.79 – 7.73 (m, 2H), 7.61 – 7.46 (m, 8H). The 
analytical data correspond to literature.
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General procedure for one-pot preparation of non-symmetric 2,2”-di-substitued bis-ortho-
azobenzenes (condition D). A solution of o-phenylendiamine (1a) (1.00 equiv) in toluene (7 
ml/mmol) was degassed under a nitrogen stream for 15 min. Then, the first nitroso compound (1.10 
equiv) and AcOH (4.00 equiv) were added. The mixture was stirred at 60°C for 18h and the second 
nitroso compound (1.00 equiv) and more acetic acid (toluene/acetic acid, 1:3) were added. After 1 
day the solvent was removed under reduced pressure. The residue was purified by flash column 
chromatography.  
One-pot preparation of 2,2”-di-substitued bis-ortho-azobenzenes (4f). The title compound 
4f was prepared according to general procedure (condition D) from o-phenylenediamine (1a) (250 
mg, 2.31 mmol, 1.00 equiv), 2-nitrosoacetanilide (2a) (417 mg, 2.54 mmol, 1.10 equiv) and 2-
nitronitrosobenzene (2c) (352 mg, 2.31, 1.00 equiv). The residue was purified by flash column chro-
matography (SiO2, hexane/EtOAc, 2:1) and the product 4f was obtained as an orange solid (450 mg, 
50%).  
One-pot preparation of 2,2”-di-substitued bis-ortho-azobenzenes (4g). The title compound 
4g was prepared according to general procedure (condition D) from o-phenylendiamine (1a) (1.80 g, 
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16.6 mmol, 1.00 equiv), 2-nitrosoacetanilide (2a) (2.73 g, 16.6 mmol, 1.00 equiv) and nitrosobenzene 
(2b) (7.13 g, 66.6, 4.00 equiv). The residue was purified by flash column chromatography (SiO2, hex-
ane/ EtOAc, 2:1) and the product was obtained in 23% yield (1.32 g). 
2-Amino-2’’’acetamido-tris-ortho-azobenzene (5a). The title compound 5a was prepared 
according to general procedure (condition B) from 2,2’’-diamino-bis-ortho-azobenzene (4i) (250 mg, 
0.790 mmol, 1.00 equiv) and 2-nitrosoacetanilide (2a) (131 mg, 0.869 mmol, 1.10 equiv). After 8 d 
the solvent was evaporated and the reaction mixture purified by flash column chromatography (SiO2, 
hexane/EtOAc, 2:1 to 1:3) and the product was obtained in 17% yield (73.1 mg). Mp 177–180 °C; 
1
H 
NMR (400 MHz, CDCl3) δ 10.81 (s, 1H), 8.68 (d, J = 8.4 Hz, 1H), 7.99 (dd, J = 8.0, 1.6 Hz, 1H), 7.91 (dd, 
J = 3.5, 1.4 Hz, 1H), 7.89 (dd, J = 3.5, 1.4 Hz, 1H), 7.88 – 7.85 (m, 1H), 7.72 – 7.57 (m, 5H), 7.51 – 7.42 
(m, 2H), 7.24 – 7.19 (m, 1H), 7.19 – 7.13 (m, 1H), 6.84 – 6.78 (m, 1H), 6.67 (dd, J = 8.2, 1.0 Hz, 1H), 
6.53 (s, 2H), 1.74 (s, 3H); 
13
C NMR (101 MHz, CDCl3) δ 169.7, 148.3, 148.1 (2C), 147.7, 141.71, 139.3, 
137.9, 134.5, 133.3, 132.54, 132.50, 132.2, 131.6, 131.3, 130.2, 127.0, 123.4, 120.6, 119.5, 118.0, 
117.8, 117.24, 117.22, 116.9, 25.2; HRMS (ESI): m/z calcd for C26H22N8O
+
 [M+H
+
] 463.1989, found 
463.1997. 
2-Amino-tris-ortho-azobenzene 5b. The title compound 5b was prepared according to gen-
eral procedure (condition B) from 2,2’’-diamine-bis-ortho-azobenzene (4i)  (250 mg, 0.790 mmol, 
1.00 equiv) and nitrosobenzene (2b) (84.6 mg, 0.790 mmol, 1.00 equiv). After 6 days the solvent was 
removed and the reaction mixture purified by flash column chromatography (SiO2, hexane/EtOAc, 
7:1) and the product was obtained in 50% yield (128 mg). Mp 156–159 °C; 
1
H NMR (400 MHz, CDCl3) 
δ 7.95 (dd, J = 8.0, 1.6 Hz, 3H), 7.92 – 7.88 (m, 1H), 7.82 (dd, J = 8.0, 1.3 Hz, 1H), 7.79 – 7.75 (m, 1H), 
7.70 (dd, J = 7.3, 2.1 Hz, 1H), 7.64 – 7.54 (m, 3H), 7.54 – 7.43 (m, 4H), 7.22 – 7.15 (m, 1H), 6.84 (t, J = 
7.0 Hz, 1H), 6.69 (d, J = 8.2 Hz, 1H), 6.64 (s, 2H); 
13
C NMR (101 MHz, CDCl3) δ 153.1, 148.7, 148.5 (2C), 
148.0, 141.5, 137.9, 133.3, 132.3, 132.1, 131.5, 131.2, 131.0, 130.3, 129.3 (2C), 123.4 (2C), 118.61, 
118.57, 117.4, 117.3, 117.0, 116.5; HRMS (ESI): m/z calcd for C24H19N7
+
 [M+H
+
] 406,1775, found 
406.1779. 
2-Nitro-tris-ortho-azobenzene 5c. The title compound 5c was prepared according to general 
procedure (condition B) from 2-amino-ortho-bisazobenzene (4b) (300 mg, 0.996 mmol, 1.00 equiv) in 
toluene (10.0 ml) and 2-nitronitrosobenzene (2c) (167 mg, 1.10 mmol, 1.10 equiv) After 6 days the 
solvent was removed under reduced pressure and the product purified by flash column chromatog-
raphy (SiO2, hexane/EtOAc, 7:1 to 1:3) to give the product in 21% yield (91.1 mg). Mp 124–126 °C; 
1
H 
NMR (400 MHz, CDCl3) δ 7.95 – 7.81 (m, 5H), 7.80 – 7.70 (m, 2H), 7.69 – 7.55 (m, 5H), 7.54 – 7.38 (m, 
5H);
13
C NMR (101 MHz, CDCl3) δ 152.9, 149.1, 148.5, 148.4, 147.6, 145.7, 135.0, 133.2, 132.3, 131.7, 
131.6, 131.5, 131.0, 130.6, 129.2 (2C), 124.0, 123.3 (2C), 120.0, 118.9, 118.7, 118.3, 117.9; HRMS 
(ESI): m/z calcd for C24H17N7O2
+
 [M+H
+
] 436.1516, found 436.1522. 
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2-Acetamido-2’’’-nitro-tris-ortho-azobenzene 5f. The title compound 5f was prepared ac-
cording to general procedure (condition B) from 2-acetamido-2’’-amino-ortho-bisazobenzene (4a) 
(368 mg, 1.03 mmol, 1.00 equiv) in toluene (17 ml) and 2-nitronitrosobenzene (2c) (172 mg, 1.13 
mmol, 1.10 equiv). After 6 d the solvent was removed under reduced pressure and the product puri-
fied by flash column chromatography (SiO2, hexane/EtOAc, 2:1) to give the product in 58% yield (293 
mg). mp 162–165 °C; 
1
H NMR (400 MHz, CDCl3) δ 10.83 (s, 1H), 8.62 (dd, J = 8.4, 1.1 Hz, 1H), 7.92 (dd, 
J = 8.0, 1.6 Hz, 1H), 7.87 – 7.80 (m, 3H), 7.76 (ddd, J = 13.4, 7.9, 1.8 Hz, 2H), 7.70 – 7.57 (m, 4H), 7.55 
– 7.44 (m, 3H), 7.44 – 7.38 (m, 1H), 7.20 – 7.13 (m, 1H), 1.70 (s, 3H); 
13
C NMR (101 MHz, CDCl3) δ 
169.6, 149.2, 148.2, 147.7, 147.6, 147.0, 145.5, 139.2, 134.2, 133.3, 133.0, 132.3, 132.1, 131.6, 
131.4, 130.8, 127.5, 124.1, 123.3, 120.6, 120.5, 118.7, 118.5, 118.4, 118.1, 25.0; MS (FAB): m/z (%) = 
493 (81%) [M
+
], 345 (100%); C26H20N8O3 (492.49): calcd C 63.41, H 4.09, N 22.75; found C 63.42, H 
4.14, N 22.60. 
2,2’’’’-Dinitro-tetra-ortho-azobenzene 6. The title compound 6 was prepared according to 
general procedure (condition B) from diamine-bis-ortho-azobenzene (4i) (250 mg, 0.790 mmol, 1.00 
equiv) and 2-nitronitrosobenzene (2c) (361 mg, 2.37 mmol, 3.00 equiv). After 4 days the solvent was 
removed and the reaction mixture purified by flash column chromatography (SiO2, hexane/EtOAc, 
2:1) and the product was obtained in 25% yield (114 mg). Mp 149–151 °C; 
1
H NMR (400 MHz, CDCl3) 
δ 7.90 – 7.83 (m, 4H), 7.80 – 7.74 (m, 2H), 7.64 (tt, J = 5.0, 2.5 Hz, 4H), 7.59 – 7.46 (m, 10H);
 13
C NMR 
(101 MHz, CDCl3) δ 148.7, 148.4, 147.7 (2C), 145.6, 133.2, 132.3, 131.7, 131.6, 130.9, 124.0, 119.6, 
119.0, 118.8, 117.8; HRMS (ESI): m/z calcd for C30H20N10O4
+
 [M+H
+
] 585.1742, found 585.1752.
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This chapter is based on the following publication. Bellotto S., Chen S., Rentero Rebollo I., Wegner 
H.A., Heinis C. Phage selection of photoswitchable peptide ligands. J. Am. Chem. Soc. 2014, 136: 
5880-5883. Reprinted with permission from the American Chemical Society. Copyright 2014. 
 
3.1 Abstract 
Photoswitchable ligands are powerful tools to control biological processes at high spatial 
and temporal resolution. Unfortunately, such ligands exist only for a limited number of proteins and 
their development by rational design is not trivial. We have developed an in vitro evolution strategy 
to generate light-activatable peptide ligands to targets of choice. In brief, random peptides were 
encoded by phage display, chemically cyclized with an azobenzene linker, exposed to UV light to 
switch the azobenzene into cis conformation, and panned against the model target streptavidin. 
Isolated peptides shared strong consensus sequences, indicating target-specific binding. Several 
peptides bound with high affinity when cyclized with the azobenzene linker and their affinity could 
be modulated by UV light. The presented method is robust and can be applied for the in vitro evolu-
tion of photoswitchable ligands to virtually any target.  
3.2 Introduction 
Photoswitchable ligands are used to control and study complex biological systems such as 
folding of proteins and peptides, enzymatic reactions or neuronal signaling.
3,31,114-118
 They are typical-
ly developed by conjugating photochromic compounds to known ligands so that exposure to light 
and a resulting conformational change of the photochrome changes the binding affinity of the lig-
and. Many light-responsive ligands are based on azobenzene, a molecule that undergoes a pro-
nounced change in geometry upon photoisomerization from trans to cis in picoseconds.
119
 It has 
been linked to a wide range of small molecule ligands or peptides such as -helices or -hairpin 
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peptides.
3,41,47,118,120,121
 For many important protein targets, photoswitchable ligands do not exist or 
they suffer from limitations such as low affinity or a small difference in affinity between the two 
conformers. The transformation of existing ligands into light-responsive ones by rational design is 
not trivial. Combinatorial strategies based on the generation and screening of large molecule librar-
ies for light-dependent binding could potentially revolutionize the development of photoswitchable 
ligands. In vitro display techniques such as phage display allow the genetic encoding of billions of 
random peptides and the identification of ligands within such pools. In recent years, strategies were 
developed to chemically modify or cyclize genetically encoded polypeptide libraries,
122,123
 or to in-
corporate unnatural amino acids.
124,125
 The availability of these novel techniques suggested that also 
photochromic compounds such as azobenzene could be incorporated into encoded peptides, and 
libraries screened.  
Two first strategies for evolving light-responsive ligands in vitro have recently been pro-
posed independently by the groups of Ito and Derda. Ito and co-workers incorporated an -(lysine)-
azobenzene photoswitch into peptides encoded by mRNA using ribosome display and amber sup-
pression.
60
 The best binder isolated to the model target streptavidin was estimated to bind with a 
micromolar binding constant. Derda and co-workers cyclized phage-encoded peptides of the form 
ACX7CG with azobenzene by connecting the two cysteines.
59
 The best light-responsive ligand, identi-
fied also against streptavidin, had an affinity of 452 M in trans conformation and showed a more 
than 4.5-fold weaker apparent affinity in cis conformation. 
Both of the two approaches generated peptide ligands that bind preferentially in trans con-
formation. This means that binders are inactivated by switching them into cis conformation by light. 
As only 70-80% of azobenzene can be switched to the cis conformation (for physical reasons), light 
cannot turn off these ligands completely. For example, if the photoswitchable peptide is an enzyme 
inhibitor, the concentration of active inhibitor is reduced maximally 5-fold, leaving most of the en-
zyme inhibited. Herein, we conceived a strategy to evolve peptide ligands that are activated by light 
rather than inactivated. Such peptide ligands bind the target when the azobenzene is switched to cis. 
A light-activatable ligand has the advantage that essentially all the peptide population (99.99%) is 
initially in the energetically favored trans conformation. In the example of the enzyme inhibitor, all 
peptide would initially be in the inactive trans conformation, leaving the enzyme fully active. Upon 
UV light exposure, all enzyme would be inhibited even if only a fraction of the ligand population is 
switched.  
3.3 Results and discussion 
Directed evolution of light-activatable peptide ligands requires that peptides are captured in 
their cis conformation, increasing the complexity of the selection process compared to the screening 
for trans binders. Combining the expertise of the Heinis laboratory in phage display and the 
knowhow of the Wegner group in azobenzene chemistry and UV spectrometry, we herein estab-
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lished the photoswitching of peptides in situ on the surface of filamentous phage. We furthermore 
developed procedures to efficiently select light-responsive peptide ligands to targets of choice. 
While all in vitro-evolved ligands reported to date bind with Kds in the high micromolar range, we 
aimed at developing binders with low micromolar or nanomolar Kds. Affinities in this range are re-
quired for most applications. 
We synthesized the photoswitchable compound 3,3'-bis (sulfonato)-4,4'-
bis(bromoacetamido) azobenzene (BSBBA) in analogy to the prototype compound BSBCA developed 
by Woolley et al.
32,126
 and applied it to cyclize the phage-encoded peptides via the side chains of two 
flanking cysteines in a similar way as Derda et al.
59
 (Figure 3.1a). BSBBA contains bromoacetamide 
that is slightly more reactive towards thiols than chloroacetamide in BSBCA.
126
 We displayed pep-
tides containing seven random amino acids flanked on each side by cysteines as fusion of pIII on 
filamentous phage (ACX7CG-phage; complexity: 2.3 x 10
8
 peptides). An engineered phage mutant 
deficient in three disulfide bridges in two domains of pIII was used.
127
 This mutant allowed applica-
tion of a broad range of reduction and alkylation conditions without affecting the functionality of the 
phage.
53,128
 We applied harsh reaction conditions to efficiently reduce the cysteines of displayed 
peptides (1 mM TCEP, 42 °C, 1 hr) and to alkylate the peptides quantitatively. 90 % of peptide was 
modified at 320M BSBBA in 20% ACN, 80% NH4HCO3, pH 8, 30 °C (Figure 3.1b and 3.1c). 
 
 
 
Figure 3.1. Phage selection of light-activated peptide ligands. (a) Schematic depiction of the selection strategy. (b) Mass 
spectrum of peptide genetically fused to phage coat protein pIII (domains D1 and D2) after incubation with 320 M BSBBA for 
1 hr (expected  mass = 454 Da). (c) Fraction of azobenzene-cyclized peptide-D1-D2 at different BSBBA concentrations esti-
mated by mass spectrometry. (d) Absorption spectra of peptide cyclized with BSBBA in the presence of phage particles. 
 
Towards the photoswitching on phage, we found that filamentous phage exposed 20 min to 
a 100 W light source ( = 365/66; distance of the cuvette = 21 cm) remained fully functional. To as-
sess if the peptides switch under these conditions, we spiked the same phage preparation with a 
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BSBBA-cyclized model peptide (H2N-AGSCHSASVCWG-CONH2; 22 M) and followed the switching by 
absorption spectrometry (Figure 3.1d). Maximal switching to cis (around 70 %) was achieved in 40 s. 
We performed selections against the model target streptavidin that was applied by the groups of Ito 
and Derda and allowed comparison of the isolated peptides.
59,60
 The CX7C phage library cyclized with 
BSBBA was subjected to two consecutive selection rounds against streptavidin as follows. The popu-
lation was first depleted of trans binders by adding and discarding 7 times 10 L magnetic streptavi-
din beads. The remaining phage were exposed 5 min to the UV light and incubated with 20 L mag-
netic streptavidin beads to capture cis binders. Binders were eluted by addition of biotin and buffer 
with a low pH (2.2). A control experiment was performed in parallel with phage-peptides that were 
not cyclized with BSBBA and exposed to UV light. Sequencing of 62 clones after two rounds of selec-
tion showed strong consensus sequences. Most peptides contained a ‘HPQ’ motif,
69,129
 that is char-
acteristic for peptides binding to the biotin-binding site of streptavidin (Figure 3.2a, left). In the con-
trol selection without BSBBA-cyclization and UV light exposure, a similar but different consensus 
sequence was observed than in the actual selection, indicating that the peptides were efficiently 
cyclized with the azobenzene compound (Figure 3.2a, right). We were pleased to find consensus 
sequences among the isolated peptides as this is a clear indication for target-specific binders. It was 
the first time that a consensus sequence was found in directed evolution of azobenzene-modified 
peptides.  
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Figure 3.2. Phage selection of light-switchable streptavidin ligands from the CX7C peptide library. (a) Peptides isolated after 
cyclization of the peptide phage library with BSBBA and exposure to UV light (left column) or without alkylation and UV light 
exposure (right column). Sequence similarities are highlighted in color. (b) Binding of peptides to streptavidin measured in a 
fluorescence polarization competition assay. Peptides are labeled with an asterisk (*) if they were selected with BSBBA and UV 
light, and with a hash symbol (#) if they were isolated as disulfide-cyclized (oxidized) peptides. 
Five peptides of the selection against streptavidin were synthesized, cyclized with BSBBA or 
oxidized to form disulfide-cyclized peptides, and the binding affinities measured in a fluorescence 
polarization competition assay. Light in the fluorescence polarization measurement did not interfere 
with the photoswitching of the peptide (Supplementary Figure S4). All peptides competed with the 
disulfide-cyclized fluorescent peptide fluorescein-AECHPQGPPCIEG (F1) which binds with a Kd of 3.1 
± 0.4 M to the biotin-binding site of streptavidin (Figure 3.2b, Appendix, Supporting table S1). The 
peptides isolated in phage selections after BSBBA-cyclization (SA101 and SA113) bound much better 
when modified with BSBBA than when oxidized. Conversely, peptides isolated in the control selec-
tion omitting BSBBA (SA116, SA124, SA129) bound worse or equal when BSBBA-cyclized. These re-
sults implied that the alkylation reaction on phage was successful and that peptides were isolated as 
BSBBA conjugates in the phage panning. All characterized BSBBA-cyclized peptides could be switched 
efficiently into the cis-conformation (50-80%) but the binding affinities of the cis and trans conform-
ers were essentially the same (Appendix, Supporting table S1). We speculated that light-responsive 
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ligands were not selected due to the long peptide loops: the amino acids next to the cysteines might 
be too flexible so that a conformational change of the linker is not transformed into a conformation-
al change of the contact-forming amino acids. In fact, an X-ray structure of a peptide with HPQ motif 
in complex with streptavidin shows that the central 3-4 amino acids including HPQ are sufficient for 
binding.
62,70
  
We subsequently turned to peptides with shorter loops. A library of the format AXCX5CXG-
phage was cloned (complexity: 1.05 x 10
7
 peptides) and subjected to affinity selections against strep-
tavidin. Isolated peptides showed four different consensus sequences (Figure 3.3a and 3.3b). Three 
out of the four consensus sequences were not found in the control selection in which BSBBA was 
omitted. This suggested that the binding of peptides of these consensus groups could potentially be 
modulated by light.  
 
 
 
Figure 3.3. Phage selection of light-switchable streptavidin ligands from the CX5C library. (a and b) Peptides isolated after 
cyclization of the peptide phage library with BSBBA and exposure to UV light (left columns) or without alkylation and UV light 
exposure (right columns). The library was either depleted from trans binders prior to UV light exposure (a) or no negative 
selections were performed (b) prior to capture of cis binders. (c) Binding of peptides to streptavidin measured by fluorescence 
polarization. Peptides are labeled with an asterisk (*) if they were selected with BSBBA and UV light and with a hash symbol 
(#) if they were isolated as disulfide-cyclized (oxidized) peptides. The binding of light-responsive ligands was measured in 
independent assays and error bars are indicated. 
 
The peptides of the XCX5CX library bound streptavidin with Kds between 1.8 ± 0.1 and 6.7 ± 2 M 
when cyclized with BSBBA (Figure 3.3c, Table 3.1). Some peptides isolated with BSBBA did not bind 
streptavidin at all when cyclized by a disulfide bridge, confirming that the peptides were selected as 
BSBBA conjugates. Upon UV light exposure, the peptides of two consensus groups changed their 
binding affinity; the cis conformers bound up to 3-fold more tightly than the peptides in trans con-
formation (Figure 3.3c and Table 3.1). 
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[a] Peptides cyclized with BSBBA, [b] Disulfide-cyclized peptides  
Table 3.1. Photo-responsive peptides.  
 
In contrast, peptides identified in the control selections without BSBBA and synthesized as BSBBA 
conjugates did not change their affinity upon light exposure (Supplementary Table S1). The change in 
affinity was quantitatively reverted by incubation in dark as shown in Figure 3.4a and 3.4b. The pep-
tides could be switched between the cis and trans conformation for several cycles without losing any 
activity, as shown for SA153 in Figure 3.4c.  
 
 
 
Figure 3.4. Switching ‘on’ and ‘off’ streptavidin-binding peptides. (a) Binding of BSBBA-cyclized peptide SA153 was measured i) 
before exposure to UV light, ii) immediately after UV light exposure, and iii) after UV light exposure and 8 hrs incubation in the 
dark. (b) Absorption spectra of SA153 after exposure to UV light for 10 or 30 seconds and incubation in the dark for the indi-
cated times. (c) Binding of SA153 to streptavidin after repetitive exposure to UV light (red dots) and incubation at 40 °C in dark 
for 1 hr (grey dots) measured in a competition fluorescence polarization assay. 
3.4 Conclusions 
In conclusion, we were able to isolate light-responsive peptide ligands that bind with Kds in 
the single-digit micromolar range and thus > 300-fold better than those developed previously with 
other in vitro evolution procedures to the same model protein target. Use of a disulfide-free phage 
mutant and custom-made libraries allowed application of robust peptide modification procedures. 
An important aspect of our approach is the switching of peptides in situ on the phage surface to the 
cis conformation, enabling the isolation of ‘activatable ligands’. The affinity difference between cis 
and trans conformation likely depends much on the target and binding site, and significantly larger 
changes may be obtained in selections with other proteins. The robust and general approach should 
be applicable for the directed evolution of light-responsive peptide ligands to virtually any target and 
promises to additionally fuel the fast growing field of optogenetics. 
Name 
Consensus 
sequence 
Kd
dark
 
a
 
(M) 
Kd
light
 
a
 
(M) 
Kd S-S 
b
 
(M) 
SA143 G_W__W 3.4±0.6 1.8±0.1 9.5±1 
SA149 G_W__W 6.7±2 2.2±0 > 250 
SA152 S_FP 3.1±0.1 2.1±0.2 11±0 
SA153 S_FP 3.6±0.3 2.0±0.5 > 250 
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3.5 Materials and methods 
Synthesis of 3,3′-bis(sulfonato)-4,4′-bis(bromoacetamido)azobenzene 
(BSBBA) 
Sodium 3,3′-bis(sulfonato)-4,4′-bis(amino)azobenzene was prepared following procedures 
developed by Woolley and co-workers.
32
 To 291 mg (0.802 mmol, 1.00 equiv.) of this compound, 
bromoacetic acid (2.67 g, 19.2 mmol, 24.0 equiv.) and bromoacetic anhydride (5.00 g, 19.2 mmol, 
24.0 equiv.) were added in a Pyrex Culture Tube Screw Cap, the tube put under nitrogen atmosphere 
and stirred at 87 °C overnight. The reaction mixture was cooled to RT, diluted to 50 mL with milliQ 
water and purified by reversed-phase chromatography on a Vydac C18 (218TP) column (22 x 250 
mm) (Grace & Vydac, Hesperia, USA) using a solvent system of H2O/0.1 % trifluoroacetic acid (TFA) 
and ACN/0.1 % TFA. After lyophilization the product was obtained in 23% yield (111 mg, 0.181 
mmol). 
1
H NMR (400 MHz, D2O) δ 8.24 (d, J = 2.2 Hz, 2H), 8.14 (d, J = 8.8 Hz, 2H), 7.90 (dd, J = 8.8, 2.1 Hz, 
2H), 4.20 (s, 4H) 
13
C NMR (101 MHz, DMSO) δ 164.73, 146.89, 137.02, 136.47, 126.16, 120.16, 
119.39, 30.56. HRMS (ESI) m/z calcd for C16H12Br2N4O8S2
2-
 [M/2]
-
 305.9227, found 305.9204.  
Peptide synthesis 
Peptides were synthesized on an Advanced ChemTech 348Ω peptide synthesizer (Aapptec, 
Louisville, USA) by standard Fmoc (9-fluorenylmethyloxycarbonyl) solid phase chemistry using Rink 
Amide AM resin (0.03 mmol scale). The coupling step was carried out twice for all amino-acids using 
0.12 mmol Fmoc-protected amino acid, 0.12 mmol HBTU, 0.12 mmol HOBt and 0.18 mmol DIEA in 
1.3 mL DMF. Fmoc groups were removed using a 20% (v/v) solution of piperidine in DMF (2 x 2.5 
mL). The peptides were deprotected and cleaved from the resin by treatment with 5 mL of cleavage 
solution (90% TFA, 2.5% phenol, 2.5% thioanisole, 2.5% 1,2-ethanedithiol (EDT) and 2.5% water), for 
3 hrs at RT under shaking. The resin was removed by centrifugation 1 min at 1000 rpm and filtration 
under vacuum. The peptides were precipitated with ice-cold diethyl ether (50 mL), incubated 30 min 
at - 20 °C and centrifuged 5 min at 4000 rpm. The precipitated peptides were washed and centri-
fuged 5 min at 4,000 rpm twice with ice-cold ether (35 and 20 mL, respectively). Samples were re-
suspended in water/ACN (ratio 5:2) containing 0.1% TFA and lyophilized. 
Peptide cyclization with BSBBA 
Crude peptide (1.00 equivalent; typically 10 mg) was reacted with BSBBA (1.1 equivalent) in 
90-50% aqueous buffer (20 mM NH4HCO3, pH 8.0) and 10-50% ACN for 1 hr at 30 °C. The product 
was purified by reversed-phase chromatography on a C18 column (Vydac C18, 218TP column, 22 x 
250 mm) using a solvent system of 99.9% H2O/0.1% TFA and 99.9%ACN/0.1 % TFA. The peptide was 
lyophilized and the mass was confirmed by electrospray ionization (ESI) mass spectrometry. 
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Peptide cyclization by oxidation 
Crude peptide (typically 10 mg) was dissolved in 9 mL aqueous buffer (20 mM NH4HCO3, pH 
8.0) and 1 mL DMSO, and incubated for 1-2 days at RT. The product was purified by reversed-phase 
chromatography on a C18 column (Vydac C18, 218TP column, 22 x 250 mm) using a solvent system 
of 99.9% H2O/0.1 % TFA and 99.9% ACN/0.1 % TFA. The peptide was lyophilized and the mass was 
confirmed by ESI mass spectrometry. 
Buffers 
Reaction buffer: 20 mM NH4HCO3, 5 mM EDTA, pH 8.0 
Washing buffer: 10 mM Tris-HCl, pH 7.4, 150 mM NaCl, 10 mM MgCl2, 1 mM CaCl2 
Modification of the peptide-D1-D2 fusion protein  
Peptide-D1-D2 fusion protein (ACGSGSGSGCG-D1-D2) was expressed and purified as de-
scribed by Angelini, A. et al.
57
 680 g of the fusion protein in 1 mL aqueous buffer was incubated 
with 1 mM tris(2-carboxyethyl) phosphine (TCEP) for 1 hr at 42 °C to reduce the cysteine residues. 
The concentration of TCEP was reduced by size exclusion chromatography on a PD-10 column (GE 
Healthcare, Uppsala, Sweden) using 20 mM NH4HCO3 buffer, pH 8. The protein (30 M) was incubat-
ed with increasing concentrations of BSBBA (80, 160, 320, 640 M) in 25% acetonitrile and 75% 20 
mM NH4HCO3 for 1h at 30 °C in a final volume of 200 L. The protein was purified by reversed-phase 
chromatography on a C4 column (Vydac C4 column, 5 µm, 4.6 x 250 mm) using a solvent system of 
99.9% H2O/0.1 % TFA and 99.9%ACN/0.1 % TFA. The mass was determined by ESI mass spectrome-
try. 
Testing photoswitching of peptide in presence of phage 
A solution of filamentous phage (10
11
 phage/mL) was spiked with the peptide H2N-
AGSCHSASVCWG-CONH2 cyclized with BSBBA in washing buffer at a concentration of 22 M and 
placed into a 1 cm quartz cuvette. The sample was irradiated with light at the 365/66 nm peak gen-
erated by a HBO 100 mercury illuminating system (100-watt high-pressure mercury plasma lamp) at 
a distance of 21 cm using appropriate filters and the absorption spectra were measured at different 
time points.  
Testing phage infectivity after BSBBA modification and UV irradiation 
Phage of the CX7C library was produced in four 0.5 L cultures as described by Rentero-
Rebollo, I. et al.
128
 Aliquots of phage (10
11
 t.u.) in 1 mL 80% 20 mM NH4CO3, pH 8.0, 5 mM EDTA and 
20% ACN were incubated with increasing concentrations of BSBBA (final concentration: 0, 40, 
80,160, 320, 640 M) for 1 hr at 30 °C. The reactions were quenched by addition of cysteine at con-
centrations 20-fold higher than those of BSBBA. The number of infective phage was measured as 
described by Rentero-Rebollo, I.
128
 et al. 2 mL of phage from the same preparation were transferred 
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to a quartz cuvette and irradiated with the HBO 100 mercury illuminating system as described above. 
At each time point (0, 30 sec, 1, 2, 4, 8, 16 min) the solution was mixed and 20 L were taken for 
phage titration. 
Cloning of the phage peptide libraries 
The phage peptide libraries CX7C and XCX5CX were cloned using a protocol described by 
Rentero-Rebollo, I. et al.
128
 The following DNA primers were used: 
 
Phage of these libraries display peptides with the following formats. The indicated sequence ‘AETV…’ 
represents the N-terminus of pIII. The complexities of the libraries are also indicated. 
 
Production of phage peptide libraries cyclized with BSBBA 
Two 2 L flasks each containing 0.5 L 2YT media and 30 g/mL chloramphenicol were inocu-
lated with TG1 E. coli cells harbouring the CX7C or the XCX5CX phage library to reach an OD600 of 0.1. 
The flasks were shaken (220 rpm) for 16 hrs at 30 °C. The cells were pelleted by centrifugation at 
8,000 rpm for 30 min at 4 °C. The supernatant was transferred to an ice-cold solution of 20% PEG, 
2.5 M NaCl (20% of culture volume) and incubated on ice for 45 minutes. Precipitated phage were 
pelleted by centrifugation at 8,000 rpm for 30 min at 4 °C. The phage pellet was resuspended in 20 
mL of reaction buffer and centrifuged at 4,000 rpm for 15 min at 4 °C. The supernatant was split into 
two fractions of 10 mL to either cyclize the peptides by BSBBA or to allow peptides to oxidize and 
form disulfide bridges. Phage in the first tube were complemented with 10 mL reaction buffer and 
TCEP (final concentration 1 mM), and incubated at 42 °C for 1 hr to reduce the cysteines. Phage were 
cooled on ice and concentrated by centrifugation at 4,000 rpm in a Vivaspin-20 filter (molecular 
weight cut off of 100,000; GE Healthcare) to 1 mL, diluted with 9 mL ice-cold reaction buffer. This 
procedure was repeated to reduce the TCEP concentration to 1 μM in 1 mL. Traces of phage stuck to 
the filter were detached by pipetting. The solution was adjusted to 4 mL with the same buffer. 1 mL 
of BSBBA in milliQ water was added to the phage to reach a final concentration of 0.32 mM and the 
Chapter 3. Phage selection of photoswitchable peptide ligands 
65 
 
reaction was incubated at 30 °C for 1 hr. Phage were separated from non-reacted BSBBA by precipi-
tation with 1 mL 20% (w/v) PEG, 2.5 M NaCl on ice and centrifugation at 4,000 rpm for 30 min. The 
phage pellet was resuspended in 1 mL washing buffer and stored at 4°C. Phage in the second tube 
were incubated with 2.5 mL ice-cold 20% PEG, 2.5 M NaCl solution for 30 min and centrifuged at 
4,000 rpm for 30 min at 4 °C. The phage pellet was resuspended in 1 mL washing buffer.  
Phage selection of photoswitchable streptavidin ligands 
The affinity selection was performed with streptavidin Dynabeads® M-280 (Life Technolo-
gies, Carlsbad, USA). Beads were blocked by exchanging the storage solution to washing buffer con-
taining 1% w/v BSA and 0.1% v/v Tween 20 and inverting on a rotating wheel (10 rpm) for 30 min at 
RT.  
For the phage selection with the CX7C library (results shown in Figure 3.2a), the following 
procedures were applied. Both, the BSBBA-modified phage (1 mL) and the oxidized phage (1 mL) 
were blocked in parallel by addition of 0.5 mL washing buffer containing 3% w/v BSA and 0.3% v/v 
Tween 20 and inversion on a rotating wheel (10 rpm) for 30 min at RT. The blocked phage were sub-
jected to seven rounds of negative selection as follows: each phage solution was incubated with 10 
L of blocked streptavidin beads and inversed on a rotating wheel (10 rpm) for 10 min. The superna-
tant was collected and incubated with 10 L of new blocked streptavidin beads. The procedure was 
repeated six times. Modified phage were split into two tubes (0.75 mL for each tube) and one of the 
two fractions was irradiated for 5 min with UV light (365/66 nm) using the HBO 100 mercury lamp as 
described above. Immediately after UV light exposure, each one of the three phage populations 
(BSBBA-modified phage irradiated, 0.75 mL; BSBBA-modified phage not irradiated, 0.75 mL; oxidized 
phage with disulfide cyclized peptides, 1.5 mL) were incubated in parallel with 20 L of blocked 
streptavidin beads and rotated on a wheel (10 rpm) for 30 min. The beads were washed four times 
with 1 mL washing buffer containing 1% BSA and 0.1% v/v Tween 20, three times with washing buff-
er containing 0.1% v/v Tween 20 and three times with 1 mL washing buffer. The bound phage were 
eluted by incubation for 5 min with 1 mL of biotin solution (30 g/ml in milliQ water). Additionally, 
remaining phage were eluted by incubation of the beads in 50 L 50 mM glycine, pH 2.2 for 5 min. 
The eluate was neutralized with 100 L 1 M Tris-HCl, pH 8.0. Eluted phage was added to exponential-
ly growing TG1 cells (OD600 = 0.4; 30 mL), incubated for 90 min at 37 °C, pelleted by centrifugation 
at 4,000 rpm for 5 min, plated on large 2YT/chloramphenicol (30 g/mL) agar plates and incubated 
over night at 37 °C. From the selection with BSBBA-treated and UV light-irradiated phage and the 
selection with oxidized phage, new phage was produced in 0.5 mL 2YT media as described above. 
Two additional rounds of phage selection were performed applying identical procedures. 
For the phage selection with the XCX5CX library, two different procedures were applied (re-
sults of the first procedure are shown in Figure 3.3a and those of the second procedure in Figure 
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3.3b). The first procedure is exactly the same as described above for the panning with the CX7C li-
brary. In the second procedure, the negative selection for depletion of trans binders was omitted. 
Labeling of peptides with fluorescein 
Peptides were labelled with fluorescein by incubating 1 mM peptide (typically 0.3 mg, 1.0 
equiv.) with 2.5 mM 5(6)-carboxyfluorescein N-hydroxysuccinimide ester (NHS-fluorescein; 2.5 equiv. 
21878 Sigma-Aldrich, St. Louis, USA) in 200 L 99,75% v/v dry DMSO and 0.25% v/v N,N–
Diisopropylethylamine (DIPEA) for 3 hrs at RT. 0.8 mL H2O containing 0.1% TFA (v/v) was added to 
the reaction mixture and the peptide purified by HPLC on an analytical C18 column (Vydac C18, 
218TP column, 4.6 x 250 mm) using a solvent system of 99.9% H2O/0.1% TFA and 99.9% ACN/0.1% 
TFA. The fluorescein-modified peptide was lyophilized and the mass confirmed by ESI-MS.  
Measuring Kd by fluorescence polarization 
Streptavidin (S4762; Sigma-Aldrich; 66 M in washing buffer) was serially diluted in washing 
buffer (final concentration range 33 M - 0.01 M). Fluorescein-labeled peptide at a concentration 
of 100 nM was prepared in washing buffer. 20 L of streptavidin and fluorescein-peptide were trans-
ferred into a well of a black 96-well half area microplate (675076 Greiner Bio-One international AG) 
and incubated at room temperature for at least 15 min. The fluorescence polarization of each solu-
tion was measured in a multiwell plate reader (Infinite® 200 PRO, TECAN, Maennedorf, Switzerland) 
using a 485 nm excitation filter and a 535 nm emission filter.  
The dissociation constants (Kd) were determined by non-linear regression analyses of fluorescence 
polarization (Fp) versus total concentration of streptavidin [P]T using the following equation.
130
 
 
Fpmin and Fpmax are the fluorescence polarization for the free peptide and the fully bound peptide, 
respectively and [L]T is the total concentration of fluorescent ligand. GraphPad Prism 5 software 
(GraphPad software) was used for the analysis. 
Competitive fluorescence polarization 
20 L of 6 M streptavidin in washing buffer was mixed with 20 L of 150 nM fluorescent 
peptide F1 (in washing buffer) and incubated for 15 minutes. 20 L of serial dilutions of sample pep-
tide were added. The sample peptide was either cyclized with BSBBA or a disulfide bridge. BSBBA-
cyclized peptide was optionally exposed to UV light for 7 min as described above. I50 (total concen-
tration of competing ligand I causing 50 % displacement of bound fluorescent peptide) was calculat-
ed with GraphPad Prism 5 software using the log(inhibitor) vs. response variable slope model. The Kd 
was determined as reported by Rossi and Taylor.
131
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Repetitive switching of light-responsive peptides 
450 L of 90 M BSBBA-cyclized SA153 in washing buffer were subjected to four iterative 
cycles of i) irradiation for 2 minutes at 365/366 nm (as described above) and ii) incubation in a water 
bath for 1 hr at 40 °C. Before the first exposure to UV light and after each cycle, two aliquots of 30 L 
were taken and their complete back-isomerization to trans was confirmed by measuring the absorb-
ance at 363 nm on a NanoDrop device (NanoDrop ND-1000 UV-Vis Spectrophotometer, NanoDrop 
Technologies, Inc. Wilmington, DE, USA). One of the two aliquots was subjected to an additional 
irradiation at 365/366 nm for 2 min. 20 L of each sample was added to 20 L of 6 M streptavidin 
in washing buffer previously incubated with 20 L of 150 nM fluorescent peptide F1. Fluorescence 
polarization was measured for all samples in parallel.  
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 Phage selection of pho-Chapter 4
toswitchable peptides inhibitors of 
uPA  
4.1 Abstract 
Photoswitchable ligands are powerful tools for the study of biological processes at high spa-
tial and temporal resolution. Recently, methods were developed to evolve photoswitchable peptide 
ligands by directed evolution techniques such as phage display. All methods employed peptides 
modified with azobenzene photoswitches and were tested with streptavidin as a model target.
59,60,132
 
A limitation of the isolated peptide ligands was the relatively small difference in binding affinity be-
fore and after photoswitching. In this work, we aimed at developing light-switchable peptides bind-
ing to a second target to see if this is a general limitation of the method. We subjected a phage dis-
play peptide library of the format XCX5CX cyclized with an azobenzene linker to affinity selections 
against the serine protease urokinase-type plasminogen activator. By high-throughput sequencing, 
we were able to identify several families of peptides that have different consensus sequences and 
inhibit uPA through different binding modes. Interestingly, peptides within the same consensus fami-
ly had similar binding properties. Overall, the change in affinity upon light exposure was again rather 
small. 
4.2 Introduction 
Recently, random strategies based on the generation and screening of large molecule librar-
ies for light-dependent binding were developed using directed evolution approaches.
59,60
 Ito and co-
workers incorporated a -(lysine)-azobenzene photoswitch into the peptide ribosome display librar-
ies with the formats X3YX7 and X7YX3 (Y = -(lysine)-azobenzene, X = any amino acid) using amber 
suppression and screened them for binding in trans conformation to streptavidin. The best binder 
was estimated to bind with a micromolar binding constant. As anticipated, it bound more tightly in 
the trans conformation. The difference in affinity between cis and trans form was not quantified.
60
 
Derda and co-workers cyclized phage-encoded peptides of the form ACX7CG with 3,3'-bis(sulfonato)-
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4,4'-bis(chloroacetamido)azobenzene (BSBCA) and screened them also for binding in trans confor-
mation to streptavidin. The best light-sensitive ligand identified had an affinity of 452 M and 
showed at least a 4.5-fold apparent weaker affinity in cis conformation.
59
 Our laboratory has recently 
developed a strategy to evolve peptide ligands that bind protein targets with higher affinity after 
light exposure.
132
 We displayed peptides flanked by two cysteines residues on phage and cyclized 
them with an azobenzene compound similar as Derda and co-workers. In contrast to this latter work, 
we isolated peptides after UV light exposure in order to capture ‘light-activatable’ binders. We suc-
ceeded in isolating a range of peptide ligands that displayed high affinity for the model target strep-
tavidin. The largest change in affinity upon UV light exposure was 3-fold.  
A limitation of all photoswitchable peptide ligands developed with the three new in vitro 
evolution strategies is the small difference in affinity between the peptides in cis and trans confor-
mation. In phage selections with our strategy, we found that peptides with similar sequences show 
similar binding properties. For example peptides isolated against streptavidin, containing the ‘HPQ’ 
sequence motif in different positions between the flanking cysteines, changed not at all their affinity 
upon switching their conformation from trans to cis. In contrast, peptides isolated against the same 
target, containing the consensus motif ‘GCWXXW’, change their binding affinity when they were 
switched into the cis conformation. Similarly, all peptides with the peptide motif ‘SCFP’ changed also 
their affinity after switching them into the cis conformation. It appeared that the extent of affinity 
change between cis and trans conformation depends much on the binding site and the manner that 
peptides bind. Peptides that mainly interact through a central motif but not the peptide termini may 
be less sensitive on a small change in the relative position of the two ends. In contrast, peptides that 
interact via the cysteines or close by residues may be much affected by a conformational change.  
In this work, we aimed at investigating the switching properties of a wider range of peptides 
that bind to different surface regions of a protein, or to the same region but by forming different 
interactions. Towards this end, we selected photoswitchable peptides against the target urokinase-
type plasminogen activator (uPA). Selections of (bi)cyclic peptides against the protease target previ-
ously yielded several groups of peptides that each shared a different consensus sequence.
57,58,82,83
 
Peptides containing different consensus sequences typically bind to the target through different 
interactions. To capture as many peptides with different binding modes as possible, we applied high-
throughput DNA sequencing to analyze many phage-selected peptides. The target uPA was primarily 
chosen as a model target to further assess the potential of phage display approach in delivering 
photoswitchable peptide ligands. However, as the function of the extracellular serine protease in 
tumor growth and invasion is not fully understood, a light-activatable inhibitor of uPA could poten-
tially be used to study the function of the protease in extracellular proteolysis and signaling in nor-
mal and tumor cells. 
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4.3 Results and discussion  
In the selections against uPA, the XCX5CX phage library was cyclized with BSBBA as de-
scribed in our previous work and two different panning procedures were applied.   
In the first one, biotinylated uPA immobilized on magnetic streptavidin beads was first add-
ed to the phage and the beads discarded to remove peptides binding in trans conformation. This 
depletion step was repeated six times. The phage were then exposed to UV light and binders cap-
tured on uPA beads to enrich cis binders. The phage were eluted, incubated in the dark to allow 
relaxation of the photoswitch and followed by another seven negative selections to remove trans 
binders that were possibly still present in solution. In parallel, a control experiment was performed 
in which the same library, not cyclized with BSBBA and not exposed to UV light, was panned against 
uPA. Several clones isolated in the selection experiment and in the control experiment were se-
quenced (Figure 4.1a). In the selection with BSBBA-cyclized peptides exposed to UV light, five differ-
ent consensus sequences were found. Most peptides were sharing the consensus sequence D
K
/R
Y
/F
T
/S 
(Figure 4.1a, left). In the control experiment, the major consensus sequence D
K
/R
Y
/F
T
/S was found too. 
Additionally, two different consensus sequences were identified (Figure 4.1a, right).      
In the second panning procedure the negative selections were omitted and the phage cap-
tured after UV light exposure. To apply more stringent conditions the irradiation and the elution 
were repeated once and twice in selection rounds two and three. Control experiments with phage 
peptide library not cyclized with BSBBA were performed in parallel in the same way. In the selection 
with peptides cyclized with BSBBA and irradiated with UV light, four consensus sequences were 
found, including the major consensus sequence D
K
/R
Y
/F
T
/S (Figure 4.1b, left). In the control selection 
omitting BSBBA-cyclization and UV light exposure, three consensus sequences were found. Again, 
most peptides were sharing the major consensus motif D
K
/R
Y
/F
T
/S (Figure 4.1b, right).   
From the sequencing result, we concluded that the peptides from the major consensus se-
quence D
K
/R
Y
/F
T
/S, found in all the four selection procedures, are binding uPA independent of the 
cyclization linker, being BSBBA or a disulfide bridge. Several of the minor consensus sequences were 
different in the BSBBA selections and the controls, suggesting that binding of some of the peptides 
depends on the linker or even linker conformation. A limitation of our analysis was that only few 
peptides were found for the minor consensus groups.  
In the last years, the development of next generation sequencing (NGS) technologies al-
lowed the analysis of massive volumes of sequences increasing exponentially the potential of in vitro 
selection methods. Our laboratory had recently applied Ion Torrent sequencing to analyze phage-
selected peptides. Further MatLab scripts were developed to evaluate vast sequence data and to 
identify consensus sequences. With these new methods, consensus sequences could be found even 
after one round of selection.
133
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Figure 4.1. Phage selection of light-switchable uPA ligands from the XCX5CX library. (a and b) Peptides isolated after cyclization 
of the peptide phage library with BSBBA and exposure to UV light (left columns) or without alkylation and UV exposure (right 
columns). Two protocols were applied to isolate cis binders: the library was either depleted from trans binders before and 
after the capture of cis binders (a) or no negative selections were performed prior to capture of cis binders (b). In the latter 
protocol, the procedure of phage capture after UV light exposure and elution was repeated once and twice in selection 
rounds 2 and 3.  
We decided to apply high-throughput sequencing to analyze a substantially higher number 
of clones to have a more detailed picture of the selected peptides and to identify even more consen-
sus sequences. The DNA of the phage isolated with the first panning strategy was PCR amplified and 
run on an Ion 316
TM
 Chip.  More than 10
4
 clones from the BSBBA-modified (Figure 4.2) and oxidized 
population (Figure 4.3) were identified, analyzed and grouped according to consensus sequence 
using the specific MatLab script. The abundance of every clone in each one of the two conditions is 
also indicated. Eleven consensus sequences were found and several sub-families could be identified 
for each one of them. Four of these consensus sequences (A, B, C, D) were found almost exclusively 
in the azobenzene modified phage population (Figure 4.2a) suggesting that the peptides were effi-
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ciently cyclized with BSBBA and that the selection could have led to the identification of target-
specific photo-modulated binders. The peptides belonging to consensus families E, F, G, H, I, J, K 
were mostly found also in the control. The high-throughput sequencing of the control selection 
clones (disulfide-bridge phage) revealed the presence of only one additional consensus sequence 
(Figure 4.3a, consensus L). The majority of the sequences were found also in the BSBBA modified 
population (Figure 4.3b).  
 
Figure 4.2. Identification of clones by Ion Torrent PGM platform. All the peptides were isolated after cyclization of the phage 
library with BSBBA, depletion from trans binders before and after the capture of cis binders. a) Consensus sequences found 
mostly or exclusively in the actual selection with modified and irradiated phage (+BSBBA + UV); b) Consensus sequences found 
also in the control selection without alkylation and UV exposure (-BSBBA - UV). (*) Abundance of each clone in the +BSBBA + 
UV condition. (#) Abundance of each clone in the -BSBBA - UV condition. 
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Figure 4.3. Identification of clones by Ion Torrent PGM platform. All the peptides were isolated after cyclization of the phage 
library by oxidation. a) Consensus sequences found mostly or exclusively in the control selection without alkylation and UV 
exposure (-BSBBA - UV). b) Consensus sequences found also in the actual selection with modified and irradiated phage (-
BSBBA - UV).  The abundance of each clone is labeled with an asterisk (*) if they were selected with BSBBA and UV light 
irradiation and with a hash symbol (#) if they were isolated as disulfide-cyclized peptides. 
To confirm the specificity of the selected clones and verify whether the inhibition of uPA 
could be modulated by UV light, several peptides found with high frequency in the consensus se-
quences A, B, C, D were synthesized and either cyclized with BSBBA or by oxidation. Their inhibitory 
activity was tested using a fluorogenic substrate. Peptides UK2015 and UK2016 (consensus sequence 
K and L respectively) isolated from the disulfide-bridge phage selection were also tested as control 
(Figure 4.4).  Light in the activity assay measurement did not interfere with the photoswitching of the 
peptide and the absorbance of BSBBA did not prevent the excitation of the fluorophore (Appendix, 
Supplementary Figure S5). UK2001 (consensus motif N_TARS) did not exhibit any change in inhibitory 
activity whether cyclized by a disulfide bridge or as BSBBA conjugates. The TAR motif is known to 
bind the target independently on the conformation as it was isolated in selections performed against 
uPA using different loop length libraries and linkers.
83
 UK2002 and UK2003 (consensus motif 
G_VYFSG and G_SVYYT respectively) showed a higher inhibition when oxidized and their activity 
seemed to do not be modulated by UV light. Peptides selected from consensus C and D did not inhib-
it the target at all when cyclized by a disulfide bridge indicating that they were selected as BSBBA 
conjugates. Furthermore they all showed (except UK2005 and UK2008) a decrease, even if modest, 
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of their inhibitory activity when irradiated by UV light (Table 4.1). Peptides with the consensus motif 
V__IIPY_R and WQERY_R presented a 2-fold change of inhibition. The results obtained with control 
peptides UK2015 and UK2016 were not clear as the inhibition assay should be repeated using higher 
peptide concentrations. All characterized BSBBA-cyclized peptides could be switched efficiently into 
the cis conformation (50-70%) and showed a half-life between 30 and 155 minutes. It was also 
shown that the peptides backisomerized when incubated in the dark and could be switched between 
the cis and trans conformation for several times without losing any inhibitory activity, as shown in 
Figure 4.5. Supporting table S2 (Appendix) summarizes the IC50 values as well as the half-life and the 
percentage of cis at the photostationary state of all the analyzed peptides.  
 
Figure 4.4. Inhibitory activity of peptides binding uPA i) BSBBA modified prior UV irradiation (green), ii) BSBBA modified after 
irradiation at 365 nm (red), iii) BSBBA modified after UV irradiation and incubation over night in the dark, iv) cyclized by 
oxidation (black). 
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Name 
Consensus 
sequence 
Selection 
 
IC50 (M) 
+ UV light 
 
IC50 (M) 
- UV light 
% cis t1/2 (min)  
IC50 S-S  
(M) 
UK2004 G_YLV_Y_R + BSBBA 1.9±0.2 1.4±0.2 68 103 * 
UK2006 YWV_Y_Q + BSBBA 16.5±3.7 12.9±3.3 55 112 >200 
UK2007 V__IIPY_R + BSBBA 1.9±0.65 0.99±0.21 66 120 >200 
UK2009 FQISY_R + BSBBA 4.5±0.5 3.4±0.3 64 74 * 
UK2010 YQISY + BSBBA 24.0±3.1 19±1.2 65 27 * 
UK2011 FQE_Y_L + BSBBA 6.9±0.6 4.7±0.65 70 116 >200 
UK2012 FQDRY_V + BSBBA 15±0.1 9.2±0.4 58 124 >200 
UK2013 WQEKY_V + BSBBA 6.3±0.25 3.8±0.45 58 102 >200 
UK2014 WQERY_R + BSBBA 0.97±0.04 0.54±0.02 59 99 >200 
Table 4.1. IC50 values, half-life and percentage of cis isomer at the photostationary state of the peptides that changed inhibito-
ry activity after irradiation. The asterisk (*) indcates the values which could not be calculated due to insolubility of the 
peptides tested.  
 
 
Figure 4.5. Absorption spectra of UK2007 after exposure to UV light for 30 seconds and incubation in the dark for the 
indicated times (left). (c) Residual uPA activity after incubation with UK2014 and repetitive exposure to UV light (red dots) and 
incubation at 42 °C in dark for 1 hr (grey dots).  
In conclusion, we have successfully applied the recently developed phage display technique 
for evolving in vitro peptide ligands containing an azobenzene linker to a second target, the serine 
protease uPA. We found again peptides that show large differences in affinity when they are cyclized 
via the azobenzene linker and a disulfide bridge. Unfortunately, the affinity change of the peptides 
upon UV exposure was again rather small. We have successfully employed high-throughput sequenc-
ing to identify a range of peptides with different consensus sequences and thus different interaction 
modes. Despite testing several peptides of different consensus families, we could not find peptides 
that show large affinity changes upon photoswitching. Our findings suggested that the conforma-
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tional change induced by the azobenzene photoswitch might be too small to achieve a sufficient 
difference in affinity and therefore lead to the amplification of phage that bind selectively in only 
one of the two conformations. Photoswitchable linkers allowing induction of a larger conformational 
change should be therefore considered in future work. 
4.4 Materials and methods 
Synthesis of 3,3′-bis(sulfonato)-4,4′-bis(bromoacetamido)azobenzene 
(BSBBA), solid phase peptide synthesis, peptide cyclization with BSBBA or 
by oxidation.  
See chapter 3. 
Phage selection of photoswitchable uPA ligands 
The phage production has been performed as described in chapter 3, materials and meth-
ods section. The affinity selection was performed with biotinylated uPA immobilized on Dynabeads
®
 
M-280 streptavidin. The catalytic domain of uPA was expressed, activated, purified and biotinylated 
as described by Chen et al.
83
 12 µg of biotinylated uPA was immobilized per 100 µL streptavidin 
beads. The protein was added to the beads and the beads were washed three times with washing 
buffer. The beads were blocked by exchanging the storage solution to washing buffer containing 1% 
w/v BSA and 0.1% v/v Tween 20 and inverting on a rotating wheel (10 rpm) for 30 min at RT.  
For the phage selection using the XCX5CX library, the following procedures were applied. In 
the first procedure, the BSBBA-modified phage (1 mL) and the oxidized phage (1 mL) were blocked in 
parallel by addition of 0.5 mL of washing buffer containing 3% w/v BSA and 0.3% v/v Tween 20 and 
inversion on a rotating wheel (10 rpm) for 30 min at RT. The blocked phage were subjected to seven 
rounds of negative selection as follows: each phage solution was incubated with 10 µL of blocked 
uPA/streptavidin beads and inversed on a rotating wheel (10 rpm) for 10 min. The supernatant was 
collected and incubated with 10 µL of new blocked streptavidin beads. The procedure was repeated 
six times. BSBBA-modified phage were split into two tubes (0.75 mL for each tube) and one of the 
two fractions was irradiated for 5 min with UV light (365/66 nm) using the HBO 100 mercury lamp as 
described above. Immediately after UV light exposure, each one of the three phage populations 
(BSBBA-modified and UV light-irradiated phage, 0.75 mL; BSBBA-modified phage not irradiated, 0.75 
mL; oxidized phage with disulfide cyclized peptides, 1.5 mL) were incubated in parallel with 50 µL of 
blocked uPA/streptavidin beads and rotated on a wheel (10rpm) for 10 min. The beads were washed 
four times with 1 mL washing buffer containing 1% BSA and 0.1% v/v Tween 20, three times with 
washing buffer containing 0.1% v/v Tween 20 and three times with 1 mL washing buffer. The bound 
phage were eluted by incubation of the beads with 50 µL of 50 mM glycine, pH 2.2 for 5 min. The pH 
was adjusted to 7.4 by adding 10 µL of 1 M Tris-HCl, pH 8.0 and 3 mL of washing buffer containing 
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1% BSA and 0.1% v/v Tween 20. After oven night incubation at RT to allow the linker backisomeriza-
tion the three populations were subjected to other seven rounds of negative selection to further 
deplete the trans binders. 
In the second procedure, the negative selection for depletion of trans binders was omitted. 
The panning (UV irradiation, capture on immobilized uPA and elution) was repeated twice and three 
times, in the second and third round of selection, respectively. After the elution in these selection 
rounds, the pH was adjusted to 7.4 by adding 10 L of 1 M Tris-HCl, pH 8.0 and 3 mL of washing 
buffer containing 1% BSA and 0.1% v/v Tween 20. 
The phage from the three different selection procedures were added to exponentially grow-
ing TG1 cells (OD600 = 0.4; 30 mL), incubated for 90 min at 37 °C, pelleted by centrifugation at 4000 
rpm for 5 min, plated on large 2YT/chloramphenicol (30 µg/mL) agar plates and incubated over night 
at 37 °C. From the selection with BSBBA-treated and UV-irradiated phage and the selection with 
oxidized phage, new phage were produced in volumes of 0.5 mL 2YT media as described above. Two 
additional rounds of phage selection were performed applying identical procedures. 
Activity assay measurements 
Inhibition of human uPA was measured by incubating 33 μL of 4.5 nM human uPA, 33 μL of 
serial dilutions of sample peptide (either cyclized with BSBBA or a disulfide bridge. BSBBA-cyclized 
peptide was optionally irradiated with UV light for 5 min as described above) in washing buffer con-
taining 1% BSA and 0.1% v/v Tween 20 and 33  μL of fluorogenic substrate Z-Gly-Gly-Arg-AMC (50 
μM final concentration in washing buffer; Bachem, Bubendorf, Switzerland). The fluorescence was 
measured over 30 min on a Tecan infinite M200 PRO® fluorescence plate reader (Switzerland; excita-
tion at 368 nm, emission recording at 467 nm). The IC50 were calculated with GraphPad Prism 5 soft-
ware using the log(inhibitor) vs. response variable slope model. 
Effect of fluorescence measurement on peptide back-isomerization 
A 1 mL solution of UK2001 (25 μM in washing buffer) was prepared and divided in two ali-
quots. One was irradiated and two samples of 100 μL each were pipetted in a 96 well plate. One of 
the two samples per condition was subjected to 10 min of fluorescence measurement with the same 
program used for activity assay (see paragraph 4.3.3). The absorbance spectrum was recorded be-
fore and after UV irradiation and fluorescence measurement.  
Interaction between BSBBA peptide and AMC  
A solution of  i) 50 μM 7-amino-4-methylcoumarin,   ii) 50 μM 7-amino-4-methylcoumarin 
and 25 μM BSBBA modified peptide ACQNSKFSGCG iii)  25 μM BSBBA modified peptide AC-
QNSKFSGCG in washing buffer were excited at 335 nm and the emission spectra were recorded from 
370 to 750 nm using a Tecan infinite M1000 PRO® plate reader (Switzerland).  
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Repetitive switching of light-responsive peptides   
1 mL of 1 μM BSBBA-cyclized UK2007 in washing buffer were subjected to three iterative 
cycles of i) irradiation for 2 minutes at 365/366 nm (as described above) and ii) incubation in a water 
bath for 1 hr at 42 °C. Before the first exposure to UV light and after each cycle, two aliquots of 50 μL 
were collected and their complete back-isomerization to trans was confirmed by measuring the 
absorbance at 363 nm on a NanoDrop device (NanoDrop ND-1000 UV-Vis Spectrophotometer, 
NanoDrop Technologies, Inc. Wilmington, DE, USA). One of the two aliquots was subjected to an 
additional irradiation at 365/366 nm for 2 min. 33 µL of each sample were used to perform activity 
assay as described above. 
Preparation of samples and analysis by high-throughput DNA sequencing   
For detailed protocols see Rentero Rebollo et al. Nucleic Acids Research, 2014.
133
 
 
 
 
 
 
 
 
 
 
Chapter 5. Conclusions 
79 
 
 Conclusions Chapter 5
5.1 Synthesis and characterization of ortho-substituted azo-
benzenes  
The aim of the first project was the synthesis of oligo-ortho azobenzenes and the study of 
their photoisomerization properties, which have not been explored systematically so far. Additional-
ly, the work with this class of molecules allowed me to gain experience in organic synthesis. Since 
only few examples of ortho-substituted multiple azobenzenes have been studied, I have prepared 
mono-, bis-, tris and tetra ortho-nitrogen-substituted azobenzenes using a procedure previously 
developed in the lab. For the synthesis of the mono ortho-nitrogen-substituted the optimized condi-
tions were used (toluene as solvent and AcOH in stoichiometric amounts) and the efficiency was 
shown to depend on the substituents. It was found that when the aniline was substituted with elec-
tron withdrawing groups its reactivity was reduced. Interestingly, the classical Mills conditions (AcOH 
as solvent) were preferred for the preparation of the bis-ortho-nitrogen-substituted and the same 
substituent effect was observed. Different asymmetric and symmetric tris- and tetra- substituted 
azobenzenes were also isolated. As expected a correlation between the number of the azobonds 
formed and the reaction time was noticed. The absorption spectra of all compounds were measured 
in chloroform and were defined by the substituents. Furthermore, only the mono-substituted azo-
benzenes could be isomerized upon UV irradiation and the presence of electron withdrawing groups 
reduced the photoisomerization properties as previously reported in literature. Several of the de-
scribed procedures are still used by other lab members for the synthesis of azobenzene derivatives. 
The reason for the inhibition of isomerization in bis-ortho-azobenzene is currently under investiga-
tion in collaboration with the group of Prof. Wachtveitl, Goethe-university, Frankfurt. 
5.2 Phage selection of photoswitchable peptides 
The main goal of my PhD thesis was the development of a phage display-based method for 
the in vitro evolution of photoswitchable peptide ligands. Recent access of phage display peptide 
libraries to chemical modification suggested that it would be possible to modify phage-encoded 
peptide libraries with photoswitchable compounds such as azobenzene. However, the method that 
looked simple and intriguing on paper had to be established experimentally. There were several 
open questions such as the following ones: i) Can peptides displayed on phage be chemically modi-
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fied with the relatively hydrophobic azobenzene compound in an aqueous buffer? ii) Does exposure 
of phage to UV light switch the peptide-linker azobenzene compound without destroying the phage 
coat or the phage DNA? iii) Can peptide ligands containing azobenzene linkers be isolated by affinity 
selection? iv) Do affinity selected azobenzene-peptides in cis and trans conformation bind with dif-
ferent affinities to the protein target? v) Is the method generally applicable to a wide range of pro-
tein targets? 
In experiments described in chapter 3, I had established the procedures to isolate peptides 
cyclized with azobenzene by phage display, using streptavidin as a model target. I was able to answer 
several of the above described questions. Peptides on phage were efficiently modified with an azo-
benzene linker via cysteines. Isolated peptide ligands were clearly dependent on the azobenzene 
linker. Peptides cyclized by disulfide bridges did not bind at all to streptavidin, or much weaker. Test-
ing of several peptides binding streptavidin revealed that some of them changed their affinity slightly 
when they were exposed to UV light and thus switched from trans into the cis conformation. We 
were highly satisfied that cyclic peptides ligands containing the azobenzene linker could be evolved 
by phage display, and that some of the peptides changed the affinity upon UV exposure. The publica-
tion of this work had raised a great deal of interest in the fields of photoswitchable ligands and pro-
tein, as well as beyond these fields. While it has been challenging to develop photoswitchable lig-
ands by rational design, this method promised to offer a general strategy to evolve photoswitchable 
peptides to virtually any target. One concern was the relatively small change in affinity when the 
azobenzene group was switched from trans to the cis conformation. It was not clear if peptides with 
larger changes in affinity could be engineered with the phage display approach. Furthermore, strep-
tavidin was a relatively easy target and it was not clear if peptide ligands cyclized by azobenzene 
could be isolated in phage selections against other protein targets. 
In order to address the open questions above, I applied the phage display approach for the 
selection of ligands to a second target, the serine protease uPA. These results are described in chap-
ter 4. An important goal was to isolate peptides that have different binding modes and bind through 
different interactions to uPA. Towards this end, I applied a high-throughput sequencing method for 
analyzing hundred-thousands of phage-selected peptides. In this way, I found peptide families with 
many different consensus sequences. A study of several of these peptides showed that they bind 
with good affinity to uPA. The binding of most peptides was again dependent on the azobenzene 
group. This finding indicated that the peptides were truly isolated as azobenzene-cyclized structures 
in the phage panning experiment. Unfortunately, several peptides did not change their affinity upon 
switching the conformation of the azobenzene moiety from trans to cis. Some peptides changed the 
affinity but the difference between cis and trans conformation was again rather small. The finding of 
relatively small affinity differences between cis and trans conformers for also the second target, uPA, 
suggested that this could be a general limitation of the approach.  
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Towards the improvement of the technology, we propose the following potential solutions: 
i) The chemical linkers used should induce a larger conformational change in the peptide. Different 
light-responsive linkers may be tested. Ideally, the distance of the thiol-reactive groups of the linker 
should change dramatically upon light exposure. ii) Different peptide libraries need to be developed 
and applied. It will be key that the amino acids close to the cysteine residues form the contacts with 
the target protein. In this way, a conformational change of the photoswitch will have a maximal 
effect on the conformation of the peptide ligands. iii) New screening protocols may need to be de-
veloped to more efficiently deplete ligands in one of the two conformations. The methods estab-
lished in this PhD thesis will offer an ideal basis to further develop the phage display-based ap-
proach. There is a high chance that the method will be applied for the directed evolution of a range 
of photoswitchable peptide ligands. 
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Appendix  
1. Supplementary information chapter 2 
 
2-Amino-2’-nitro-ortho-azobenzene (3c) 
1
H NMR (400 MHz, DMSO) 
 
13
C NMR (101 MHz, DMSO) 
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2-Acetamido-2’nitro-ortho-azobenzene (3h) 
1
H NMR (400 MHz, CDCl3) 
 
 
13
C NMR (101 MHz, CDCl3) 
 
 
 
 
 
Appendix 
84 
 
2-Amino-ortho-bisazobenzene (4b) 
 1
H NMR (400 MHz, CDCl3) 
 
 
13
C NMR (101 MHz, CDCl3) 
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2-Amino-2’’-nitro-ortho-bisazobenzene (4c)  
1
H NMR (400 MHz, CDCl3) 
 
 
13
C NMR (101 MHz, CDCl3) 
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2-Nitro-ortho-bisazobenzene (4d)  
1
H NMR (400 MHz, CDCl3) 
 
 
13
C NMR (101 MHz, CDCl3) 
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2-Acetamido-2’’-nitro-ortho-bisazobenzene (4f)  
 1
H NMR (400 MHz, DMSO) 
 
 
13
C NMR (101 MHz, CDCl3, δ/ppm)  
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2-Acetamido-ortho-bisazobenzene (4g)  
1
H NMR (400 MHz, CDCl3) 
 
 
13
C NMR (101 MHz, CDCl3) 
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2-Amino-2’’’acetamido-tris-ortho-azobenzene (5a)   
1
H NMR (400 MHz, CDCl3) 
 
 
13
C NMR (101 MHz, CDCl3) 
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2-Amino-tris-ortho-azobenzene (5b)   
1
H NMR (400 MHz, CDCl3) 
 
 
13
C NMR (101 MHz, CDCl3) 
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2-Nitro-tris-ortho-azobenzene (5c)   
1
H NMR (400 MHz, CDCl3) 
 
 
13
C NMR (101 MHz, CDCl3) 
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2-Acetamido-2’’’-nitro-tris-ortho-azobenzene (5f)   
1
H NMR (400 MHz, CDCl3) 
 
 
13
C NMR (101 MHz, CDCl3) 
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2,2’’’’-Dinitro-tetra-ortho-azobenzene (6)  
1
H NMR (400 MHz, CDCl3) 
 
 
13
C NMR (101 MHz, CDCl3) 
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Figure S1. Absorption spectra of the ortho-amino (Figure S1a), acetamido (Figure S1b) and nitro (Figure S1c) substituted 
mono-azobenzenes in chloroform. 
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Figure S2. Photoisomerization of the ortho-nitrogen substituted mono-azo-benzenes in chloroform.  
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Figure S3. Absorption spectra of the ortho-amino (Figure S3a), acetamido (Figure S3b), nitro (Figure S3c) and hydrogen (Figure 
S3d) substituted bis-azobenzenes 4 in chloroform. 
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2. Supplementary information chapter 3 
 
 
 [a] Peptides cyclized with BSBBA, [b] Disulfide-cyclized peptides, [c] Kds below 1 M could not be determined accurately in 
the competition assay as the concentration of streptavidin monomer was 8 M. 
Supporting table S1. Photo-responsive peptides. The binding affinity was measured multiple times and standard deviations 
are indicated.  
 
 
Figure S4. Effect of fluorescence polarization measurement on peptide back-isomerization. Absorption spectra of BSBBA-
modified peptide (20 M in PBS, peptide sequence ACVWHPQVPCG) before irradiation (- UV light), at the photostationary 
state after irradiation at 365 nm (+ UV light), after irradiation and incubation in the darkness for 10 min (+ UV light & incuba-
tion in dark), and after irradiation and fluorescence polarization measurement in a plate reader for 10 min (+ UV light & fluo-
rescence polarization measurement). 
Name Library 
Consensus 
sequence 
Selection 
Kd
dark
 
a
 
(M) 
Kd
light
 
a
 
(M) 
% cis 
t1/2 
(min) 
a
 
Kd S-S 
b
 
(M) 
SA101 CX7C WHPQ + BSBBA < 1
c
 < 1
c
 67 66 > 20 
SA113 CX7C SAP_GSL + BSBBA 4.8 4.7 71 50 9.9 
SA116 CX7C HPQ_D - BSBBA 3.6 4.1 73 62 1.5 
SA124 CX7C HPQ_D - BSBBA 6.9 6.2 72 60 6.5 
SA129 CX7C SSP - BSBBA 5.6 5.4 72 80 9.2 
SA136 XCX5CX HPQ_P +/- BSBBA 3.3 3.6 75 64 6.1 
SA143 XCX5CX G_W__W + BSBBA 3.4±0.6 1.8±0.1 58 103 9.5±1 
SA149 XCX5CX G_W__W + BSBBA 6.7±2 2.2±0 63 130 > 250 
SA152 XCX5CX S_FP + BSBBA 3.1±0.1 2.1±0.2 74 112 11±0 
SA153 XCX5CX S_FP + BSBBA 3.6±0.3 2.0±0.5 70 103 > 250 
SA160 XCX5CX HPQ_P - BSBBA 5.4 5.2 74 59 6.5 
Appendix 
98 
 
3. Supplementary information chapter 4 
 
Figure S5. Effect of activity assay measurement on peptide back-isomerization. a) Absorption spectra of BSBBA-modified 
peptide (peptide UK2001, 25 μM in washing buffer) before irradiation (- UV light), at the photostationary state after irradia-
tion at 365 nm (+ UV light), after irradiation and incubation in the darkness for 10 min (+ UV light), and after irradiation and 
activity assay measurement in a plate reader for 10 min (+ UV light & activity assay measurement).  
b) Emission spectra of i) 50 μM 7-amino-4-methylcoumarin (AMC), ii) 50 μM 7-amino-4-methylcoumarin and 25 μM BSBBA 
modified peptide ACQNSKFSGCG iii)  25 μM BSBBA modified peptide ACQNSKFSGCG in washing buffer excited at 335 nm. The 
inhibitory activity of one representative peptide should be tested with a chromogenic substrate (ex. H-Glu-Gly-Arg-pNA) in 
order to exclude the possibility that AMC emission induces the backisomerization of the azobenzene moiety. 
 
Name 
Consensus 
sequence 
Selection 
 
IC50 (M) 
+ UV light 
 
IC50 (M) 
- UV light 
% cis t1/2 (min)  
IC50 S-S  
(M) 
UK2001 N_TARS + BSBBA n.d. n.d. 63 64 n.d. 
UK2002 G_VYFSG_R + BSBBA n.d. n.d. 64 97 11 
UK2003 G_SVYYT + BSBBA n.d. n.d. 63 102 n.d. 
UK2004 G_YLV_Y_R + BSBBA 1.9±0.2 1.4±0.2 68 103 * 
UK2005 P_YVISW + BSBBA 80 78 57 97 * 
UK2006 YWV_Y_Q + BSBBA 16.5±3.7 12.9±3.3 55 112 >200 
UK2007 V__IIPY_R + BSBBA 1.9±0.65 0.99±0.21 66 120 >200 
UK2008 FYVPY_Q + BSBBA 10.8 10.4 64 155 >200 
UK2009 FQISY_R + BSBBA 4.5±0.5 3.4±0.3 64 74 * 
UK2010 YQISY + BSBBA 24.0±3.1 19±1.2 65 27 * 
UK2011 FQE_Y_L + BSBBA 6.9±0.6 4.7±0.65 70 116 >200 
UK2012 FQDRY_V + BSBBA 15±0.1 9.2±0.4 58 124 >200 
UK2013 WQEKY_V + BSBBA 6.3±0.25 3.8±0.45 58 102 >200 
UK2014 WQERY_R + BSBBA 0.97±0.04 0.54±0.02 59 99 >200 
UK2015 P_ERG_E +/- BSBBA n.d. n.d. 64 57 n.d. 
UK2016 G___LGT_F - BSBBA n.d. n.d. 64 63 n.d. 
Supporting table S2. IC50 values, half-life and percentage of cis isomer at the photostationary state of all the analyzed pep-
tides. The asterisk (*) indicates the values which could not be calculated due to insolubility of the peptides tested. (n.d.) 
indicates the values that could not be determined precisely because the plateau of the residual activity could not be reached.  
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